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ABSTRACT 
Low Cost Optical Imaging Systems for Early Detection of Oral Cancer 
b y 
Mohammed Saidur Rahman 
Optical imaging has the potential to improve early detection of oral cancer. 
Reflectance and fluorescence based optical devices have demonstrated improved 
sensitivity and specificity compared to conventional visual oral examination. Although 
these devices are increasingly used as clinical tools in developed countries, they are a less 
practical solution in low-resource settings as the cost of these devices is relatively high, 
their portability is limited, and results from them are often subjective. This dissertation 
focuses on development of optical imaging platforms that specifically addresses these 
challenges and can be used to aid in screening and detection of oral pre-cancers. 
The first part of this dissertation describes the construction and evaluation of a 
macroscopic imaging system with multi-modal imaging capability. This system can be 
used to screen the surface area of oral tissue at risk to detect abnormal sites. It is low-
cost, portable and battery powered, which is ideal for screening and detection of oral 
cancer in high-risk populations in low-resource and remote settings. The system was 
evaluated in a clinical study in India and results from the study were used to develop a 
computational algorithm for objective interpretation of images from the system. In 
addition, this system was used to characterize optical properties of pathological 
conditions that are population specific. Results from this trial system are promising and 
show that normal oral sites can be differentiated from high-risk and cancerous sites with 
high sensitivity and specificity. Although results show that sites with low-risk can be 
differentiated from normal tissue using this system, the sample size of the low-risk 
measurements is relatively small and they can not be differentiated from high-risk and 
cancerous tissue. 
The second part of this dissertation involves developing a low-cost and simple 
microscopic system that is capable of high-resolution imaging for early detection of 
cancer. It was demonstrated that the 'optical-sectioning' concept of structured 
illumination can be integrated with optically active exogenous contrast agents for high-
resolution molecular-specific imaging of pre-cancer. Finally, this dissertation also 
incorporates evaluation of a multi-modal miniature microscope (4M) device developed 
based on structured illumination. Results from the system show that the device is capable 
of high-resolution imaging and can be used with molecular-specific contrast agents for 
detection of cancer and its precursors. 
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Chapter 1 
Introduction 
1.1 MOTIVATION 
Oral cancer is a major global health problem. It is estimated that more than 
400,000 new cases of oral cancer will be diagnosed in 2008 worldwide making it the 
sixth most common malignancy in the world1. Oral cancer disproportionately impacts 
patients in developing countries. According to the World Health Organization (WHO), of 
the estimated 145,500 annual deaths from oral cancer worldwide, nearly two-thirds of 
them occur in developing countries.2'3 In South Asian countries oral cancer is one of the 
most common cancers with incidence rate reported as high as 13 per 100,000 per year.4 
The mortality rates in south Asia are almost twice as global rates, making it an important 
public health problem for this region.5 
The screening of patients for signs of oral cancer and precancerous lesions has 
relied upon conventional oral examination (COE). However, there are several drawbacks 
to this approach resulting in poor survival rate for oral cancer patients. First, oral cancer 
is frequently associated with development of multiple tumors which are often missed 
during primary diagnosis and therapeutic intervention.6 Second, detection relies heavily 
on clinical experience at recognition of suspicious lesions with variable effectiveness.7'8 
Third, there is increasing awareness that many pre-cancerous lesions are clinically occult 
and not visible under conventional visual and tactile examination.9 These asymptomatic 
lesions can be easily ignored or missed by patients and health care professionals.10 Thus, 
new techniques which can aid in screening and detection of changes associated with oral 
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pre-cancers and can be implemented in low-resource settings and developing countries 
would be an important contribution to global efforts to reduce oral cancer mortality and 
morbidity. 
Recently, optical technologies have emerged as potential aid for early detection of 
oral cancer. Reflectance and fluorescence based optical devices have demonstrated 
improved sensitivity and specificity compared to conventional visual oral examination.10" 
22
 Currently optical technologies are a less practical solution in low-resource settings 
because the cost of these devices is relatively high, their portability is limited, and they 
require a stable, high-voltage power supply. This dissertation focuses on development of 
optical imaging platforms that specifically addresses these challenges and can be used as 
an aid in screening and detection of oral pre-cancers. 
1.2 SPECIFIC AIMS 
My research goal is focused on developing optical technologies that are low-cost 
and can aid in screening and detection of oral cancer in remote settings with limited 
resources and facilities. Specifically, I have worked on two multi-modal imaging 
platforms to meet this goal: 1) a widefield system with low-resolution imaging capability 
and 2) a microscopic system with high-resolution imaging capability. The former is 
designed to screen the surface area of oral tissue at risk to detect abnormal sites with high 
sensitivity while the later is designed to detect molecular changes in tissue to achieve 
high diagnostic specificity. In addition to the above two imaging platforms, I have 
evaluated a miniature microscope designed by our collaborators at the University of 
Arizona with various biological specimens including tissues from oral cavity. My 
research goals of this Ph.D. thesis were as follows: 
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1. Develop a low-cost, multi-modal, portable widefield imaging system for 
screening and early detection of oral cancer. 
2. Evaluate the developed optical system in a high-risk population where oral 
cancer is prevalent. 
3. Implement a high-resolution microscopic imaging technique involving 
structured-illumination on a conventional microscope for molecular imaging of 
pre-cancer with contrast agents. 
4. Evaluate imaging performance of a miniature micro-endoscope for high 
resolution imaging of biological specimens including pre-cancers. 
1.3 DISSERTATION OVERVIEW 
In this dissertation, Chapter 2 describes background information on epithelial 
precancer, fluorescence and reflectance imaging principles for early detection of cancer, 
and the concept of high-resolution imaging with structured illumination. Chapter 3 
describes the design and construction of a low-cost, portable widefield imaging system 
with presentation of a brief set of clinical data. Chapter 4 presents evaluation of the 
developed portable screening system at Tata Memorial Cancer Hospital in Mumbai, 
India. Chapter 5 describes implementation of structured-illumination technique on a 
conventional bench-top microscope for high resolution molecular-specific imaging of 
pre-cancer. Chapter 6 presents the imaging results of a multi-modal miniature microscope 
(4M) from various biological specimens. Finally, Chapter 7 presents summary and 
conclusion of this research. 
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Chapter 2 
Background 
This chapter contains a review of the material necessary to understand the patho-
physiology of oral cancer and the rationale behind optical imaging for its early detection. 
First, I describe the clinical significance of oral cancer and the need for early detection 
especially in developing countries and present an overview of the pathology of oral 
cancer. Second, I present a discussion of reflectance and fluorescence optical imaging 
principles for early detection of oral cancer. Third, I describe the imaging concept of 
structured-illumination and how this technique can be used together with molecular-
specific contrast agents to obtain high resolution images of the molecular and 
morphological changes associated with oral pre-cancer 
2.1 EARLY DETECTION OF ORAL CANCER 
Oral cancer accounts for 2% to 3% of all malignancies and has one of the lowest 
five year survival-rates of all major cancers.6'24"28 In the U.S., the population-based five-
year survival rate for patients with oral cancer is approximately 54%.' If diagnosed early, 
while the disease is still localized, the survival rate increases to more than 80%.' 
However, for the vast majority of patients, the disease is diagnosed late, when oral cancer 
is at an advanced stage with regional and distant metastases. Thus, the five-year survival 
rate seldom exceeds 42% for those patients with regional disease and 19% for those who 
have disease with distant metastases.29 
In developing countries, the five-year survival rate is strikingly lower compared to . 
developed countries. For example, the average five-year survival rate for oral cancer is 
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only 30% in selected developing countries compared to 54% in the developed countries.30 
Furthermore, even when the disease is at a localized stage and chances of survival is 
high, that survival rate is only 60% for developing countries as compared to 80% for the 
U.S and other developed countries. Figure 2.1 compares five year survival rate at 
different stages of oral cancer for the U.S. and India. 
Local Regional Distant 
Figure 2.1. Five-year survival rate of oral cancer in the U.S. and India 30 
The key to improving survival of oral cancer is to improve screening and early 
detection. Recently, one large trial conducted in southern India examined the impact of 
screening on detection of oral cancer in a high-risk population vs. the general population. 
The study concluded that screening for oral cancer in high-risk population could reduce 
37,000 deaths each year due to the disease. It also found that screening is less effective 
in the general population due to the large number of false positive referrals when 
screening with conventional oral examination (COE). Thus, new techniques which can 
aid screening and early detection of oral cancer effectively and can be implemented in 
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low-resource settings (i.e. developing countries) would be an important contribution to 
global efforts to reduce oral cancer mortality and morbidity. 
2.2 PATHOLOGY OF ORAL CANCER 
The oral cavity consists of multiple anatomic sites including the buccal mucosa, 
lips, palate, and the floor of mouth as shown in Figure 2,2a. The entire oral cavity is 
lined by stratified squamous epithelium which is divided into two main broad types. The 
masticatory epithelium covers the surfaces which are involved in processing of food 
(tongue, gingivae and hard palate). This type of epithelium is keratinized to different 
degrees depending on the extent of physical forces exerted. Lining epithelium is non-
keratinized stratified squamous which covers the remaining surfaces including the buccal 
mucosa, lateral border of tongue, lips and the floor of mouth. Underlying the epithelium 
is connective tissue or stroma composed primarily of fibrous proteins such as collagen 
and elastin but also including fat cells, cartilage and blood vessels.31 In between the 
stroma and the epithelium lies the basal cell layer and the basal lamina or basement 
membrane. Basal cells are responsible for cell division and production. These cells are 
smaller than the epithelial cells and are cuboidal or columnar in shape as shown in Figure 
2.2b. As the basal cells continue to divide, they are pushed up towards the top of 
epithelium displacing the older cells at the surface. 
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a b 
Figure 2.2. Anatomy and architecture of the oral cavity: (a) major anatomical sites of 
the oral cavity, (b) epithelial tissue of the oral cavity. Adapted from Ref. 21 and 22. 
Oral squamous cell carcinoma (OSCC) originates in the epithelium. As normal 
healthy tissue comes in contact with carcinogens from tobacco, ionizing radiation, 
infectious organisms and other environmental toxins, changes that are precursor to OSCC 
can develop in the epithelium.33 Over time, the accumulation of genetic damage can 
cause epithelial cells to undergo neoplastic transformation resulting in the development 
of intraepithelial neoplasia. Ten or more years can pass between the exposure and 
initiation of the disease in the epithelium and the external appearance of a tumor.34"35 
Intraepithelial neoplasia begins at the basal layerof the epithelium. The loss in the 
cellular uniformity and architectural orientation is known as dysplasia.32 When the 
abnormal cells occupy approximately the lower one-third of the epithelium, the tissue is 
known as mildly dysplastic. As the cells continue to divide and abnormal cells occupy 
about one-half of the epithelium, the tissue becomes moderately dysplastic. Finally, 
when the entire epithelium is full of abnormal cells, the tissue is classified as carcinomain 
situ. At this point, the cells can invade the basement membrane and metastasize to other 
Gingiva 
Hard 
Palate 
Tonsil 
Tongue 
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areas of body resulting in invasive cancer. This dysplasia-to-carcinoma progression 
sequence is illustrated in Figure 2.3. 
Figure 2.3. Illustration of cancer progression in an epithelial 
tissue at various stages. 
During neoplastic progression, oral epithelial tissue undergoes various 
morphological and biochemical changes both at microscopic and at macroscopic level. 
Morphological changes of tissue at microscopic level include loss of polarity of basal 
cells, enlargement of cellular nuclei, variations in nuclei size and shape, and increased 
nuclei-cytoplasmic ratio. ' " In addition, structural changes such as thickening of the 
epithelium, neo-vascularization, and degradation of protein filaments and collagen cross-
links in the stroma are also common.36"37 Biochemical changes include changes in 
concentration of certain biomolecules including the cofactor reduced nicotinamide 
adenine dinucleotide (NADH), flavins, collagen, elastin and porphyrins.37^0 Neoplastic 
progression also accompanies molecular changes and overexpression of certain 
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biomarkers such as epidermal growth factor receptor (EGFR), matrix metalloproteinase 
(MMPs), and vascular endothelial growth factor (VEGF).37"43 
Neoplastic progression in the oral cavity is also generally preceded by 
premalignant lesions or conditions that are visible macroscopically. Most common of 
these conditions include erythroplakia, leukoplakia, lichen planus, ulcer and oral 
submucous fibrosis. Figure 2.4 shows some of these premalignant conditions. Each 
condition has different morphological representation, and their epidemiology and 
etiological factors may vary from one specific population to the other. For example, oral 
submucous fibrosis is a rare premalignant condition among western population but it is 
dominant in south Asia. Its etiology is mostly attributed to chewing of betel leaves and 
areca nuts that have extremely high carcinogenic potential.6 
9 
Erythroplakia Leukoplakia 
Oral Submucous Fibrosis Lichen Planus 
Figure 2.4. Images of common premalignant conditions in the oral cavity. 
10 
Oral erythroplakia is defined as red lesion of the oral cavity that can not be 
removed and is not attributable to a specific cause.6 Erythroplakia has the highest 
malignant transformation rate compared to all other mucosal lesions varying from 14% to 
50%.6'44 Up to 50% of these lesions are invasive OSCC, 40% are carcinoma in situ, and 
9% have mild-to-moderate dysplasia.6'45"47 It can be accompanied by white patches as in 
leukoplakia in which case the lesion is called erythroleukoplakia. Leukoplakia is defined 
as any white patch or plaque that cannot be removed and is not attributable to a specific 
cause.6 Malignant transformation of leukoplakia varies between 3.6% to 17.5%.6 
Leukoplakia that occurs on the floor of mouth and on the tongue has a higher rate of 
malignant transformation. One aggressive form of leukoplakia is verrucous leukoplakia 
which begins as a simple hyperkeratosis and progress to become multifocal and 
proliferative with wart-like, verrucal and exophytic feature.6 Verrucous leukoplakia has 
been reported to have 70.3% malignant transformation to verrucous carcinoma and has 
high recurrence rate after treatment.48"51 Lichen planus appears as patches of fine white 
lines and dots which usually do not cause problems. The status of lichen planus as a 
premalignant condition is often disputed.6 Several studies have shown that the 
transformation rate of lichen planus to OSCC is between .04% to 1.74%.44'52 However, 
severe forms of oral lichen planus can cause painful sores and ulcers in the mouth 
potentially leading to malignant transformation. 
Oral sub-mucous fibrosis (OSF) is a premalignant condition that is population 
specific to south Asia with potential risk of malignant transformation. OSF is a chronic, 
progressive, and irreversible disorder that can affect any part of the oral cavity.53 
Clinically, it is characterized by paleness of oral mucosa, oral ulceration, a burning 
11 
sensation in the presence of spicy food, hardening of the tissue and presence of fibrous 
bands.54 The fibrosis also leads to gradual onset of inability to open the mouth and 
protrusion of tongue, difficulty in mastication, speech, and swallowing with pain in the 
throat and ears. The malignant transformation is estimated to be between 3% and 19%.55 
Another oral condition common in these populations is melanosis. However, unlike 
OSF, melanosis is considered benign and rarely associated with malignant 
transformation.56 Melanosis consists of dark, pigmented patches on the inside of the oral 
cavity induced by tobacco use. The common sites for melanosis are gingiva, buccal 
mucosa and tongue. It is caused by increased production of melanin to provide a biologic 
defence against noxious agents present in tobacco and occurs up to 21.5% of smokers and 
usually disappears within three years of smoking cessation.54 
The malignant transformation rate for the above oral premalignant conditions also 
differs according to lesion characteristics and their location in the oral cavity. Lesions of 
the floor of the mouth, tongue, and lower lip are associated with higher rates of dysplasia 
and malignant transformation.23 Table 2.1 show most common locations of oral cancer 
and the corresponding incidence rate for each location. 
Table 2.1. Most common sites of cancer in the oral cavity24 
Location 
Tongue 
Lip 
Floor of Mouth 
Gingivae & Others 
Incidence (%) 
30% 
17% 
14% 
26% 
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2.3 OPTICAL IMAGING FOR EARLY DETECTION OF CANCER 
Optical imaging technologies have been demonstrated to aid in detection oral 
neoplastic lesions with high sensitivity and specificity.57"60 The advantages of optical 
imaging over other imaging modalities include they are inexpensive, robust, portable and 
can provide near real-time diagnostic information either non-invasively or minimally 
invasively. Optical imaging relies on the interaction between light and tissue to detect 
early changes associated with the dysplasia-to-carcinoma sequence. The morphological 
and biochemical changes that accompany neoplastic progression affect the light 
absorption, scattering and fluorescence properties of tissue. These changes can be 
detected with a number of reflectance and fluorescence optical imaging techniques 
including wide-field, confocal and structured-illumination system. The reflectance-based 
imaging techniques rely on the variation of index of refraction among the cellular and 
tissue compositions, which absorb and scatter light differentially to produce image 
contrast. Fluorescence-based imaging systems, on the other hand, rely on certain 
absorbers and fluorophores in tissue to produce image contrast. The intensity and color 
of the fluorescence also provide important biochemical information about the tissue 
including its composition, presence or absence of certain fluorophores as well as its 
metabolic activities. Beside the native sources of contrast present in cells and tissue, 
certain exogenous contrast agents can also be introduced for optical imaging. These 
contrast agents generally have higher scattering properties and quantum efficiency for 
reflectance and fluorescence imaging respectively, and yield higher signal-to-background 
contrast than native sources. 
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2.3.1 Fluorescence Imaging 
Fluorescence is the process by which excitation light evokes emission of light of a 
different wavelength. The excitation light is usually in the near-UV to visible range and 
the emitted fluorescence light is in the visible to near-infrared range. Fluorescence is the 
result of a process that occurs in certain molecules called fludrophores in which photon 
energy supplied by the excitation light source is absorbed by the molecule, creating an 
excited electronic singlet state.61 The fluorophores remain in the excited state for a short 
period of time and return to the ground state. When the fluorophores return to the ground 
state, photons with energy lower than the excited photons are emitted as fluorescence. 
There are many endogenous fluorophores in tissue with distinct optical properties. 
Figure 2.5 shows excitation and emission spectra of important fluorophores that are 
reported to be associated with neoplastic development including NADH, FAD, 
tryptophan, porphyrin, collagen and elastin.62 The NADH or reduced form of 
nicotinamide adenine dinucleotide and the FAD or oxidized form of flavin adenine 
dinucleotide, are indicators of cellular metabolism and are located predominantly within 
the mitochondria of cells. Thus, NADH and FAD-induced auto-fluorescence originates 
from the epithelial layer of tissue where cells are metabolically active and go through 
continuous division. Maximum NADH fluorescence occurs at 340-nm excitation and 
450-nm emission wavelengths while that of FAD occurs at 450-nm excitation and 530-
nm emission wavelengths. Drezek et al and Pavlova et al found that NADH 
fluorescence increases with neoplastic progression while that of FAD decreases.37"38 
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Figure 2.5. Excitation (top) and emission spectra (bottom) of some native fiuorophores in 
tissue associated with neoplasia. Adopted from ref. 62. 
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Another source of fluorescence in the epithelial tissue is collagen and elastin, 
which are fibrous proteins that predominantly make up the stroma under the basement 
membrane. Together, they provide a strong supporting structure for the epithelial tissue. 
Collagen and elastin autofluorescence are associated with their enzymatically activated 
crosslinks. Collagen has maximum fluorescence at 340-nm excitation and 390-nm 
emission wavelengths while that of elastin occurs at 350-nm excitation and 420-nm 
emission wavelengths. At near-UV to visible wavelength excitation of healthy tissue, 
epithelial autofluorescence is mostly attributed to collagen and elastin crosslinks.63 
However, collagen- and elastin-related autofluorescence in premalignant lesions have 
been reported to decrease significantly possibly due to the breakdown of crosslinks in 
collagen and elastin.37"38 The increased thickness of epithelial layer due to neoplastic 
progression is also considered a likely cause for this decrease in fluorescence.61 Other 
important factors that contribute or affect auto-fluorescence in tissue include porphyrin 
and hemoglobin. Porphyrin has a distinctive fluorescence characteristic with a maximum 
intensity at 400-nm excitation and 635-nm emission. The affinity of porphyrin to 
malignant tissue has been much studied and is somewhat debatable.59 A most common 
theory is that porphyrin-like fluorescence is a product of microbial porphyrin synthesis, 
and therefore, is only limited to necrotic surface of exulcerated tumors.59'64"67 Another 
important factor that affects tissue autofluorescence is hemoglobin. The amount of blood 
vessels present in certain tissues has shown to influence the autofluorescence 
characteristic of the tissues.36'61 Hemoglobin in blood has a strong light absorption 
property, and absorbs both excitation and emitted fluorescence light. In neoplastic tissue, 
angiogenesis results in an increased microvascular density and the amount of blood in the 
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tissue. This increase in the concentration of blood in tissue decreases the overall tissue 
autofluorescence. 
2.3.2 Reflectance Imaging 
Reflectance imaging involves detection of the same wavelength(s) of emitted light 
that are illuminated on the tissue. Reflectance-based techniques rely on absorbers and 
scatterers of light in tissue to produce morphological and biochemical information. Most 
common sources of reflectance contrast that are pertinent to neoplastic tissue include 
cellular nuclei and their chromatin content, tissue morphology and architecture, and 
hemoglobin.68 The nuclear size and nuclei-to-cytoplasmic ratio increases with neoplastic 
progression. Drezek et al. have shown through modeling and experimentation that this 
increase in nuclear size and overall nuclei-to-cytoplasmic ratio increases the light 
scattering from the epithelium.37 The scattering properties of the stromal layer 
underlying the epithelium also change with neoplastic progression. It is believed that the 
morphological structure of collagen and elastin changes and the volume fraction of the 
fibers decreases as dysplasia develops, leading to decreased scattering from the stroma.69 
Hemoglobin plays an important role in absorption of light in the stromal layer. Increase 
in hemoglobin concentration due to increased microvascular density and angiogenesis 
increase the light absorption properties of tissue. 
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Figure 2.6. Schematic of contrast agents (indicated with yellow spheres) bound to 
epidermal growth factor receptors (EGFR) on the cell membrane. Adapted from ref. 70. 
2.4.3 Imaging with Contrast Agents 
Molecular specific contrast agents are exogenous fluorophores or contrast 
materials that can be used to highlight specific molecules of interest and probe their 
presence in cells and tissues. They enhance the contrast of target molecules that have 
either poor or no contrast. A number of contrast agents are currently being studied for 
optical imaging that can highlight up-regulated proteins in neoplastic cells and tissues 
such as epidermal growth factor receptor (EGFR), vascular endothelial growth factor 
(VEGF) receptor and matrix metalloproteinase (MMPs). The contrast agents can be 
divided into two categories according to imaging modalities: reflectance and fluorescence 
contrast agents. Reflectance contrast agents such as gold and silver nanoparticles are 
used to probe molecules in reflectance imaging while fluorescence contrast agents such 
as quantum dots and dyes are used for fluorescence imaging. Although there are many 
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more contrast agents, my discussion in this dissertation is limited to only two of these 
contrast agents: gold nanoparticles and quantum dots. 
Gold nanoparticles are colloidal gold nanospheres made from the reduction of 
auric acid with sodium citrate.71 They have the ability to scatter light very strongly over 
a narrow band wavelength due to the excitation of surface plasmon resonance and 
collective oscillation of electrons in electric field.71 They scatter light in the visible and 
near IR wavelength which can be easily detected using reflectance imaging systems. 
Sokolov et al. have demonstrated the use of conjugated gold nanoparticles with 
monoclonal antibodies to successfully image cancerous cells and tissues in reflectance 
mode.72 Imaging with a reflectance confocal microscope, the authors have demonstrated 
that the anti-EGFR gold nanoparticle conjugates label only premalignant cells and 
tissues. They found that the strong light-scattering from the gold nanoparticles bound to 
the cell membrane of the premalignant cells and tissues allows one to see cellular 
morphology clearly and probe the presence of cancer biomarker EGFR. 
Another type of contrast agent that has recently been widely used for optical 
imaging applications is quantum dots. Quantum dots are semiconductor nanocrystals 
with a quantum-confinement property that enables them to emit different colors of light.73 
Thus, they are used for fluorescence imaging applications. Quantum dots (QDs) are 
bright with broad absorption property in the blue region of visible spectrum while they 
have narrow emission property from the visible to the near IR region of the spectrum. 
Due to the large separation between their excitation and the emission wavelengths or 
Stokes' shift, quantum dots result in much higher signal-to-background ratio than 
conventional fluorescence dyes or contrast agents. Another advantage of the quantum 
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dot is they are not prone to photo-bleaching. A number of studies have shown the 
potential of using quantum dots for diagnosis of cancer.73"75 
2.4 STRUCTURED-ILLUMINATION 
In any imaging application, resolution of the imaging system plays a vital role in 
differentiating morphological features in cells and tissue. Molecular-imaging, in 
particular, requires reflectance and fluorescence imaging systems that has the ability to 
delineate molecular features both in lateral and in axial direction. Although the lateral 
resolution in a conventional wide-field microscope can provide fine details of cells and 
tissue, its axial resolution is often poor. Confocal microscopy is generally used to obtain 
high resolution images both in lateral and in axial direction. One drawback, however, is it 
is much more complex and expensive. The structured illumination technique is a simple 
alternative to complex confocal microscopy technique that improves the axial resolution 
of a conventional widefield imaging system.76 It was first proposed by Wilson et al. for a 
widefield microscope and later was extended to macroscopic imaging systems.77"80 The 
authors demonstrated that the axial resolution of a conventional microscope could be 
dramatically improved to approach that of a confocal microscope through the optical-
) sectioning of imaging object using structured grid patterns and subsequent mathematical 
processing of acquired images. ~ 
'Optical sectioning' refers to faithful imaging of objects that are within the depth-
of-field Of a microscope without any out-of-focus light. In a conventional widefield 
microscope, objects in the image plane include features that are both within and outside 
of the depth-of-field of the microscope, resulting in image 'blurring'. Structured 
illumination technique modifies the illumination path of a widefield microscope so that 
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the out-of-focus contributions can be differentiated from the in-focus components, 
producing optically sectioned images similar to confocal microscopes. In mathematical 
terms, in a conventional widefield microscope all but the zero (a.k.a. DC) spatial 
frequency components attenuate with defocus. The zero spatial frequency corresponds to 
unwanted background and noise generated from regions outside the depth-of-field of the 
microscope and causes the image 'blurring'. This out-of-focus light reduces contrast and 
affects details that are within the system's depth-of-field. The key to generating 'optical 
sectioned' images lies in that all spatial frequencies including the zero must be attenuated 
with the defocus of the optical system. To accomplish this, a single-spatial-frequency 
grid pattern is projected onto the focal plane of a microscope through its conjugate focal 
plane. The one dimensional grid pattern can be represented in optical coordinates (t,w) as 
S(f0,w0) = l + mcos(vf0+p0), Eq. [I] 
where (p is arbitrary phase and v is the normalized spatial-frequency related to actual 
spatial frequency, v, by v = v-fi-X/NA; fl is the magnification between grid pattern and 
object plane, NA is the numerical aperture of the objective lens and X is the wavelength of 
light. The projection of the grid pattern on the object plane is such that all spatial 
frequencies in the object plane except the zero frequency will have 'optical signatures' on 
them and the resulting image can then be written as 
I(t,w) =Ig+ Iccosf + Issinf. Eq. [2] 
Here, 10 represents conventional wide-field image with both in- and out-of-focus 
components, Ic and Is represents images that are due to grid pattern of form m cos (vto) 
and m sin (vto). From Eq 2, we notice that only the non-zero spatial frequency 
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components or objects within the depth-of-field have grid pattern while zero spatial 
frequency components or objects outside the depth-of-field does not have any pattern. 
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Therefore, in order to recover non-zero spatial frequency components without the grid 
patterns, at least three images (//, h, and I3) are needed with the grid pattern shifted by a 
third of a cycle or spatial phase of the pattern each time (cpO=0, cp0=27t/3 and (p0=4n/3). 
Finally, the optically sectioned image (Ip) can be generated by applying the simple square 
root method. Since the zero spatial frequency components do not have any grid pattern, 
they will simply cancel out. Figure 2.7 shows a graphical representation of obtaining 
optical sectioning using structured illumination. 
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Figure 2.7. A schematic of structured illumination technique. 
22 
Wilson et al. have demonstrated high-resolution optical sectioning ability of 
structured illumination both in reflectance and in fluorescence imaging mode. In 
fluorescence mode, the technique was demonstrated with lily pollen grain and COS-7 
kidney cells.78 The group also demonstrated real-time three-dimensional imaging of 
wrist watch mechanism in reflectance mode.79 
One fundamental drawback to structured illumination is that in order for optical 
sectioning to produce high resolution images, sufficient contrast must be present in the 
sample. The endogenous sources of contrast in many biological samples including cells 
and tissues do not provide the contrast needed for structured illumination due to their low 
scattering or quantum yield property. The useful in-focus contrast information can be 
limited to even as low as two gray levels of the camera, and standard algorithms are not 
capable of effectively reconstructing images of the in-focus section under these 
conditions. Furthermore, reflectance imaging of tissue is generally sensitive only to non-
specific differences in refractive index, and provides rather limited information about the 
range of molecular changes associated with patho-physiology. The magnitude of the 
refractive index difference between the nucleus and cytoplasm in epithelial cells is small 
(An~0.02), thus the signal from the optical section is small compared to the multiply-
scattered out-of-focus light. Simple, non-specific contrast agents such as acetic acid 
(vinegar) are used routinely in clinical cancer detection and can enhance nuclear 
backscattering several fold7, but the magnitude of the in-focus signal compared to the 
out-of-focus signal is still small. Similarly, the endogenous fluorophores present in tissue 
have very low quantum efficiency. To image these samples, exogenous contrast agents 
such as gold nanoparticles and quantum dots or dyes must be used. Thus, integrating 
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structured illumination with contrast agents can provide a simple way of obtaining high-
resolution images for detection of cancer and precancer. This concept of integrating 
structured illumination with molecular specific contrast for high resolution imaging is 
described in detail in Chapter 5. 
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Chapter 3 
Low-Cost, Multi-Modal, Portable Screening System for Early Detection of 
Oral Cancer. * 
3.1 INTRODUCTION 
Oral cancer is an important global health problem that disproportionately impacts 
patients in developing countries. According to the World Health Organization (WHO), 
the worldwide annual incidence for oral cancer exceeds 267,000 new cases with an 
estimated 145,500 deaths, nearly two-thirds of which occur in developing countries2. 
Overall survival rates for oral cancer in developing countries are low and there has been 
little improvement over the past three decades. In the vast majority of cases today, oral 
cancer is diagnosed at an advanced stage, when it requires more aggressive treatment and 
results in poor survival and increased morbidity. However, one large screening trial 
conducted in southern India demonstrated that early detection of oral cancer in high risk 
populations can reduce mortality3. Thus, new techniques which can aid diagnosis of 
changes associated with oral cancer at an early stage and can be implemented in low-
resource settings would be an important contribution to global efforts to reduce oral 
cancer mortality and morbidity. 
The standard method for screening and detection of oral neoplasia is visual 
inspection of oral cavity under white light. Unfortunately, the clinical appearance of oral 
'This chapter is modified from: M. Rahman, A. Gillenwater, R. Richards-Kortum; 
"Low-Cost, Multi-Modal, Portable Screening System for Early Detection of Oral 
Cancer, "Journal of Biomedical Optics Letters, 13(3), 0305020 (2008). 
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cancers at an early stage can be difficult to differentiate from nonspecific inflammation 
and irritation under white light examination. Fluorescence imaging has been shown to be 
an effective alternative method for screening and diagnosis of pre-cancers in several 
organ sites including oral cavity, uterine cervix, lung and skin everal groups including 
Betz et al, Onizawa et al, Paczona et al and Sivstun et al have shown that examining the 
oral cavity under a fluorescence excitation light source can overcome some of the 
detection limitations associated with standard white light examination ' " . Lane et al 
recently proposed a simple hand-held device for direct visualization of tissue 
autofluorescence above 480nm using a metal halide mercury lamp with excitation 
wavelengths between 360-460nm60. The device is currently approved for medical use by 
the Food and Drug Administration (FDA) in the U.S. 
Although previous fluorescence imaging devices have shown high sensitivity and 
specificity for detecting abnormalities in the oral cavity, their use has been mainly limited 
to medical facilities in developed countries. They are a less practical solution for mass 
screening of high-risk populations in low-resource settings as the cost of these devices is 
relatively high, their portability is limited, and they require a stable, high-voltage power 
supply. Furthermore, it is difficult to use these devices to perform traditional white light 
examination, which may prevent clinicians from obtaining clinical impressions they are 
accustomed to observing. In this chapter, we present a simple yet robust optical system 
that can be used for both white light reflectance examination and fluorescence imaging. 
The head-mounted device presented here can be used for direct visualization by the 
health care provider, as well as for digital acquisition of images of the oral cavity. This 
inexpensive and portable device utilizes light-emitting diodes (LED) as its illumination 
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source and can be powered by a compact lithium-ion battery. This approach not only 
makes the device low maintenance and affordable but also makes it usable in low 
resource settings where a stable source of electrical power may not be available. 
Altogether, the features of the optical device make it easily translatable to developing 
countries for screening oral cancer. 
3.2 INSTRUMENTATION 
A schematic diagram and picture of the optical device, named the portable 
screening system (PS2 Oral), is shown in Fig 3.1. The system is designed for direct 
visualization and digital imaging for wide-field macroscopic inspection of the oral cavity. 
It has multi-modal imaging capabilities including white-light reflectance, orthogonal 
polarization and fluorescence. There are three principal components to the system: 
illumination, detection and system integration. Detail attention was given in selection of 
each of the components such that the system could be adaptable to conditions in remote 
locations and low-resource settings. In this section, we discuss each of the components in 
detail. 
3.2.1 Illumination 
Ideal imaging system requires light sources that have very uniform fields, 
excellent control of relative intensity and known spectral contents. Traditionally, halogen 
lamps have been used for white light and reflectance imaging due to their uniform 
spectral characteristics in the visible-near IR wavelengths. For fluorescence imaging 
applications, high power arc lamps such as xenon and mercury lamps are commonly 
used. The arc lamps provide high irradiance required to excite endogenous and 
exogenous fluorophores, and generate fluorescence. However, there are several 
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Figure 3.1. Schematic diagram (top) and picture (bottom) of the portable 
screening system for oral cancer. 
28 
drawbacks to these conventional light sources that limit the use of existing fluorescence 
imaging devices such as the VELScope in only resourceful settings such as medical 
facilities in developed countries. First, the cost of the light sources can be significant due 
to its highly-regulated voltage supply. Second, they require high voltage power supply 
that is often not available in low-resource and remote settings. Third, arc lamps are 
inherently unstable due to fast changes in the electron density in the generated plasma 
and thermal runaway84. Fourth, these light sources have very limited portability due to 
safety concerns and the weight of the sources. 
An alternative to traditional reflectance and fluorescence illumination sources is 
light emitting diodes (LEDs). Recent advances in high performance LED technology 
have offered a cheap, stable and easy-to-use solution for light source that can be used in a 
wide variety of imaging applications84"87. A number of commercial vendors now produce 
high-performance LED that provides sufficient intensity at specific wavelengths 
especially for fluorescence imaging applications. The advantage of LED over traditional 
light sources include their compact size, low power consumption, minimal heat output, 
fast switching and adjustable properties, high emission stability and extremely long life 
span85. All of these advantages play a crucial role for use of our desired imaging system 
in low-resource and remote settings. 
The use of light emitting diodes as illumination source for autofluorescence 
imaging of the oral cavity is new and has not been explored previously to the best of our 
knowledge. Most studies that have reported use of LED in fluorescence applications 
involves imaging with exogenous contrast agents, which have higher quantum efficiency 
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than endogenous fluorophores. To determine whether LED can be used as excitation 
light source for endogenous fluorophores such as collagen and elastin, the required 
minimum irradiance at tissue was investigated. Trujillo et al have reported fluorescence 
quantum efficiency (QE) of cervical epithelial tissue varying from 0.0006 for normal to 
0.0003 for precancer at 460-nm excitation88. Based on this quantum efficiency, 
Benavides et al. found that a CCD camera with detection sensitivity of 8e-15 W per pixel 
can detect autofluorescence with an irradiance of 1.3 mW/cm2 at the tissue with signal-to-
noise ratio (SNR) of 10 89. For our PS2 imaging system, a 750mW blue LED (Luxeon 
Royal Blue- K2) with 455-nm wavelength was considered for fluorescence illumination. 
This light source provided a peak irradiance of 15mW/cm2 at the center of the 
measurement at a working distance of 25 cm. Thus, the illumination intensity of our 
LED far exceeds that required for fluorescence illumination of tissue provided that a 
CCD with similar specifications as above is used. For reflectance illumination, a white 
LED (Heine USA) was used; its intensity was comparable to the conventional white 
lights used by health care professional for regular clinical examination of the oral cavity. 
Figure 3.2 shows intensity profile of the illumination light sources across the field-of-
view of the PS2 system. 
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Figure 3.2. Intensity profile of the LED light sources in PS2 imaging system. 
One important parameter for fluorescence illumination source is the excitation 
wavelength(s) desired for optimum emission of fluorophores. Ideally, an illumination 
light source should only have the excitation wavelength(s) at which the quantum 
efficiency for the desired fluorophore(s) has maximum emission peak. Extensive studies 
have been conducted by various research groups in understanding both how bio-
fluorophore concentration changes with dysplastic progression and what optimal 
wavelengths are best for probing the changes. Utzinger et al. have shown that the 
optimal excitation wavelengths for detecting abnormal oral tissue are between 420 and 
440 nm90. Svistun et al. extended the previous work on freshly resected oral tissue and 
found that best sensitivity and specificity were achieved with excitation wavelengths 400 
nm and 440 nm, and emission collection between 500 and 560 nm ' . Based on these 
works and others, Lane et al. used metal halide mercury lamp with excitation peak at 
405-nm and 436-nm for their hand-held fluorescence device commercially available as 
VELScope. The Luxeon Royal Blue light emitting diode selected for the PS2 system had 
an excitation peak at 455nm. This is not the optimum excitation wavelength suggested in 
the literature. However, the selection of the PS2 fluorescence illumination source was 
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limited by the commercial availability of the LEDs, their maximum irradiance at tissue 
and their peak intensity wavelength. Figure 3.3 shows the wavelength profile of the royal 
blue LED used for fluorescence illumination in the PS2 system. 
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Figure 3.3. Relative intensity vs. wavelength of PS2 LED fluorescence illumination 
source. 
3.2.2 Detection 
Selection of right camera is crucial in any imaging systems especially for 
fluorescence imaging applications. Fluorophores with low quantum efficiency requires 
highly sensitive detector. At the same time, the weight and size of a sensitive detector 
can limit its portability and usage in clinical settings. In addition to these factors, our 
detector selection was also limited by its power consumption rate, which must be low 
enough such that it can be powered by battery in remote locations. For our imaging 
system, we selected a head-mount color CCD camera (Prosilica EC1380C) that can be 
used for both reflectance and fluorescence imaging. The 1.3 megapixels camera weights 
only 89grams and has a dimension of 33mm x 46mm x 66mm. The CCD contains a 
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progressive scan chip (Sony ICX285AL, Exview HAD) with 6.45um x 6.45um size 
pixels and a sensitivity of 0.02 lux at 100ms exposure time. At this sensitivity, the 
camera can detect 1.2e"15 W per pixel. This detection sensitivity is much higher than the 
required specification to detect the minimum fluorescence emitted from tissue with the 
excitation of our light source. The power consumption of the camera was less than 3W 
and could be supplied by firewire interface via laptop computers for remote use. A 
graphical-user-interface (GUI) software was written in LabView (National Intruments) to 
control the camera and acquire images. 
3.2.3 System Integration 
In order to integrate the desired illumination and detection components discussed 
above, a commercially available surgical headlight system (Heine, USA Ltd) was 
modified. The headlight system provided a supporting frame to hold the illumination 
source and the detector together. The headlight system also provided a lithium-ion 
battery which could be used to power the illumination source of the PS2 system 
continuously for four hours. For visual detection, a pair of binocular loupes (Heine USA 
Ltd) with 2.5x magnification was purchased. The loupes had two functions: it provided 
magnified view of the observation sites, and served as filter holder in front of the eyes for 
visual observation of fluorescence emission from tissue. The binocular loupes provided a 
field of view (FOV) of 55 mm at a working distance (WD) of 25 cm, with a depth-of-
field (DOF) of 55mm. The spatial resolution of the system was tested with a USAF 
resolution target and up to four lines pairs per millimeter could be resolved. 
In order to record images from tissue in different modalities including 
fluorescence, standard white light and orthogonal polarized modes, appropriate optical 
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components were introduced in the optical light path. For fluorescence illumination, a 
447/60 nm excitation filter (Semrock FF02-447/60) was placed in front of the blue LED 
to prevent any bleed-through above 480 nm. The emitted fluorescence could be observed 
or detected through 480 nm long pass emission filters (Omega Optical 480ALP). 
Similarly, for orthogonal polarized light reflectance imaging, a linear polarizer was 
placed in front of the white LED light; an additional linear polarizer oriented at 90° 
relative to the first was placed in the detection light path. This simultaneously blocks 
specular reflection and allow observation of lesions and deeper tissue structures such as 
microvasculature which may not exhibit high contrast under standard white light 
illumination91. The long-pass filter and polarizer in the detection path of the camera 
were placed using a custom designed filter holder. This holder contains three positions to 
allow different optical components to be easily interchanged during patient examinations 
in different imaging modalities. The total cost of the PS2 system as assembled here was 
approximately $4,500 excluding the cost of the PC. The system cost can be reduced to 
$1,200 by replacing the scientific grade camera with a low cost camera which is sensitive 
enough to detect autofluorescence. We estimate that the final cost could be drastically 
reduced to less than $100 by eliminating the camera altogether, but this would eliminate 
the capability for recording imaging data for clinical or research purposes. 
3.3 PRELIMINARY RESULTS 
The system was used to obtain images of the oral cavity from normal volunteers 
and from patients suspected to have oral cancer at the UT MD Anderson Cancer Center. 
Following image acquisition in consenting patients, clinically suspicious areas of tissue 
were biopsied and submitted for histopathologic diagnosis. In addition, the system was 
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used to image the oral cavity of consenting patients at the Tata Memorial Hospital in 
Mumbai, India. 
Figure 3.4. Digital images of the floor of mouth from a normal volunteer using the 
portable screening system: (a) fluorescence (b) standard white-light reflectance, and (c) 
orthogonal polarized white-light reflectance images. 
Figure 3.4 shows images of the floor of mouth of a normal volunteer obtained 
using different imaging modalities with the portable screening system.Although the 
bright fluorescence signal from the teeth partially saturates the image, green 
autofluorescence signal from tissue is clearly visible in Fig. 3.4a. Similarly, in the 
standard white light image, strong specular reflection in some regions partially saturates 
the image and hinders observation of underlying tissue structures. In comparison, in the 
orthogonal-polarized image, the specular reflection is removed allowing good 
visualization of the sub-epithelial vasculature as shown in Fig. 3.4c. 
Figure 3.5 shows images of the oral cavity from three patients obtained using the 
portable screening system. The top row shows images from the floor of mouth of Patient 
A; the arrow in the fluorescence image indicates an area with strong loss of fluorescence; 
in contrast, the standard white light image and the orthogonal polarized white light 
images of the same area showed no obvious clinical abnormalities. Both the white light 
images show the proposed region of tissue to be resected drawn by the surgeon based on 
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clinical judgment. The histo-pathology report confirmed an area with dysplasia within 
this region. 
In addition, Figure 3.5 shows images from two patients with clinically apparent 
lesions. Although histopathology was not available in these patients, regions of loss of 
fluorescence correlate well with clinically suspicious areas. Images are shown from 
Patients B and C with leukoplakia in the left buccal mucosa. In both cases, there is a 
strong loss of fluorescence associated with the area of leukoplakia. Images from Patient 
B show a region of increased redness in the orthogonal polarized image just beneath the 
area of leukoplakia (arrows); this also corresponds to a region of decreased fluorescence. 
Images from the contralateral normal buccal mucosa in Patient C show homogeneous 
fluorescence across the tissue. 
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Figure 3.5. Images of the oral cavity from three patients obtained with the portable 
screening system: (left column) fluorescence images, (middle column) standard white-
light reflectance images, and (right column) orthogonal polarized white-light reflectance 
images. 
37 
3.4 DISCUSSION 
The potential of the PS2 system to help differentiate between normal and 
dysplastic oral tissue is demonstrated in Figs. 3.4 and 3.5. In contrast to the images from 
the normal volunteer, the autofluorescence signal from dysplastic tissue in Patient A 
shows a characteristic loss of autofluorescence. Similarly, in Patients B and C, mucosal 
areas with lesions clinically suspicious for dysplasia also show characteristic loss of 
autofluorescence. This is consistent with previous research using more costly scientific 
grade instruments; this loss of autofluorescence is attributed to a decrease in stromal 
collagen and elastin fluorescence which underlies the dysplastic epithelial tissue . 
Furthermore, the use of orthogonal polarization imaging reduces interfering specular 
reflection and enhances contrast associated with subsurface vasculature which is 
frequently increased in neoplastic lesions. 
In summary, images obtained with the PS2 system in-vivo demonstrate that it is 
an attractive technology to explore for cancer screening in low-resource environments 
where clinical expertise is often unavailable. The device incorporates LED illumination, 
and can be used in both white light and fluorescence imaging modes. It is battery 
powered and can acquire digital images of tissue with an integrated CCD camera. These 
stored images can be used in longterm clinical surveillance, for telemedicine review by 
clinical experts, and potentially for incorporation of automated image analysis 
algorithms. Overall, these features, coupled with the low cost of the system, make it an 
attractive option to explore for oral cancer screening in low-resource settings. Further 
clinical trials in a controlled, prospective setting are required to evaluate the diagnostic 
performance of the device and to determine the degree of clinical expertise required to 
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use it effectively. Athough the device is designed for screening for oral cancer, it can be 
translated to other organ sites. Furthermore, as new understandings in optical properties 
of normal and diseased tissue are conceived and advances in LED technologies are made, 
they can be easily incorporated into the PS2 system to improve the device. 
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Chapter 4 
Evaluation of A Low-Cost, Portable Imaging System for Screening and 
Early Detection of Oral Cancer1 
4.1 Introduction 
Oral cancer is a major health problem worldwide, causing over 127,000 deaths 
each year1. With an annual incidence exceeding 274,000 cases, oral cancer ranks as one 
of the top ten most common malignancies. Over two-thirds of cases and three-quarters of 
deaths due to oral cancer occur in developing countries.2 In the U.S., the overall five-
year-survival rate for patients with oral cancer is only 54%, one of the lowest rates of all 
major cancers; in developing countries, five-year survival rates drop below 30%.1,3 
Patients with early lesions have better chances for cure and less treatment associated 
morbidity, yet despite the easy accessibility of the mouth, most patients present with 
advanced tumors, when treatment is more difficult, more expensive and less successful 
compared to earlier interventions. Early detection of oral premalignant lesions (OPLs) 
and early neoplastic changes may be our best and most cost-effective means to improve 
survival and quality of life for oral cancer patients from all socioeconomic communities.3 
No satisfactory mechanism exists currently to screen and detect early neoplastic 
changes of the oral cavity in the general population. Possible explanations include: 1) 
Limited public awareness and insufficient education of health care workers about oral 
cancer risk factors, signs and symptoms. 2) Detection relies heavily on clinical 
'This chapter is modified from: M. Rahman, N. Ingole, D. Roblyer, V. Stepanek, R. 
Richards-Kortum, A. Gillenwater, S. Shastri, P. Chaturvedi; "Evaluation of A Low-Cost, 
Portable Imaging System for Early Detection of Oral Cancer, " TBA. 
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experience at recognition of suspicious lesions during physical examination, with 
variable effectiveness.9'10 It can be difficult to distinguish OPLs from more common 
inflammatory conditions. 3) Practitioners and patients are reluctant to perform invasive 
biopsies of oral lesions which are expensive and often require referral to a specialist. 4) 
Some patients have field cancerization, where the entire mucosal lining that is exposed to 
carcinogens in alcohol and tobacco sustains damage and is at risk to develop cancer.92 In 
high risk patients, often the whole lining of the oral cavity is potentially premalignant, 
making it difficult even for experienced clinicians to know when and where to biopsy.9 
The situation is even more challenging in developing countries and low-resource regions 
with high-risk populations, where a combination of lack of public awareness of the 
disease and inadequate resources and expertise for screening can result in even greater 
delays in diagnosis, leading to higher morbidity and mortality. 
Recent advances in optical imaging have the potential to improve early detection 
of oral cancer and its precursors. Several groups have demonstrated that imaging 
systems that record the spatial distribution of tissue fluorescence at specific 
excitation/emission wavelength combinations can be used to survey large areas of oral 
cavity mucosa to non-invasively detect early changes associated with oral cancer in real-
time.9'59"61'81"83 Lane presented a non-magnifying hand-held device for direct 
visualization of oral cavity tissue fluorescence, which is now FDA approved for clinical 
use and commercially available as the VELscope®.5 The system uses a metal-halide lamp 
with emission peaks at 405 and 436 run to excite autofluorescence; images viewed by eye 
through the VELscope indicate a characteristic loss of fluorescence associated with 
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malignant progression. Results from 50 biopsies taken from areas with loss of 
fluorescence in 44 patients showed a sensitivity of 98% and specificity of 100% for 
discriminating normal tissue from severe dysplasia, carcinoma in situ, or invasive 
carcinoma, using histology as the gold standard. An important finding was the ability of 
fluorescence visualization to aid clinicians in identifying early neoplastic lesions that 
were initially missed during traditional white light examination (WLE).93 
To be useful in low resource settings where the vast majority of oral cancers 
occur, screening aids must be affordable and must not rely on significant clinical 
expertise for image interpretation. The ability of fluorescence-based screening aids to 
differentiate precancerous lesions from benign lesions such as inflammation must also be 
validated in larger trials. Finally, the optical properties of other potentially confounding 
lesions, which may be population specific, must be characterized. For example, betel 
quid use is common in south Asia and is associated with a high incidence of OPLs as 
well as other potentially confounding oral lesions, including melanosis and oral 
submucous fibrosis (OSF).54"56 
To address the need for objective image interpretation, Roblyer recently described 
a multimodal digital microscope to obtain digital images of oral tissue fluorescence and 
reflectance and evaluated the ability of objective image analysis techniques to recognize 
OPLs and early oral cancer. Using 405 nm excited fluorescence images, algorithms 
could detect OPLs and oral cancer with a sensitivity of 94% and specificity of 87% in 64 
patients.94 The results of automated analysis of digital autofluorescence images must also 
be validated in larger clinical trials. 
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While digital image analysis can provide more objective interpretation, lower cost 
devices are needed for use in developing countries. To address the need for low-cost 
imaging, Rahman recently developed a multi-modal imaging system for screening and 
detection of oral cancer in high-risk populations in low-resource and remote settings.95 
This portable, battery powered system acquires near real-time digital images of oral 
tissue in reflectance and fluorescence mode. In this paper, we report results of a clinical 
study to evaluate the ability of this device to aid in detection of oral cancer in India 
involving 109 subjects at high-risk for developing oral cancer. We also characterize the 
optical properties of two types of potentially confounding oral lesions, melanosis and oral 
submucous fibrosis (OSF), which are common in this region, and discuss how the 
presence of these lesions influences the ability of the device to accurately identify 
neoplastic lesions. 
4.2 Materials and Methods 
4.2.1 Instrumentation 
The portable imaging system used in this study consisted of a modified 
commercial headlamp system; details of the device have been described previously.95 
Briefly, the multi-modal imaging system uses light emitting diodes (LEDs) to illuminate 
the oral mucosa. For fluorescence imaging, the system has a blue LED with an excitation 
peak at 455 nm wavelength; for reflectance imaging, it has a white LED with an 
illumination range of 400 to 700 nm. Images can either be observed visually or captured 
digitally through a set of optical filters using an integrated, miniature charge coupled 
device (CCD) camera. The system is connected to a laptop via a firewire interface to 
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record and store the images. The portable system weights only three pounds and can be 
powered by a lithium-ion battery. 
4.2.2 Protocol and Image Acquisition 
The study was conducted at Tata Memorial Hospital (TMH) in Mumbai, India. 
Patients who were referred to the Cancer Prevention Clinic at Tata Memorial Hospital 
because of suspicious oral lesions or were waiting for head & neck surgery in the hospital 
ward were recruited to participate in the study. In addition to patients, normal volunteers 
with and without a history of using tobacco were recruited to participate in the study. The 
clinical study was reviewed and approved by the Hospital Ethics Committee (HEC) at 
TMH and the image analysis study was reviewed and approved by the Institutional 
Review Board at Rice University. Written informed consent was obtained from each 
subject enrolled in the study. 
In vivo imaging measurements from subjects were obtained in the Cancer 
Prevention Clinic. All measurements were taken in a darkened room to avoid room light 
interference. The imaging system was positioned approximately 20 cm away from the subjects. 
Reflectance image exposure was a few milliseconds while fluorescence image exposure was 
approximately 500 milliseconds. 
A head & neck specialist at the clinic assessed each participating patient by 
conducting a conventional examination of the oral cavity. Initial clinical impression of 
each site as normal or abnormal was noted. For each clinically abnormal site, clinical 
descriptors were noted, including the following categories: melanosis, lichen planus, 
OSF, hyperkeratosis, ulcer, leukoplakia, erythroplakia, and/or cancer. After clinical 
examination, digital reflectance and fluorescence images were obtained from clinically 
abnormal sites and contralateral clinically normal sites. Images were also obtained from 
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the lateral border of the tongue, the buccal mucosa, and the lip of each subject whenever 
these sites were accessible. A quality control check was performed on all images before 
further analysis. Sites with poor image quality (e.g. out-of-focus images) were excluded 
from analysis. 
For sites with an initial clinical impression of abnormal, the white light 
reflectance images were reviewed by three expert observers who were blinded to the 
fluorescence images (NI, AG, PC). At each site, the observer noted one or more clinical 
descriptors for the lesion, including: melanosis, lichen planus, OSF, hyperkeratosis, ulcer, 
leukoplakia, erythroplakia, and/or cancer. In addition, each site was assigned a single 
diagnostic category of 'Normal', 'Low Risk for Neoplasia', 'High Risk for Neoplasia', or 
'Cancer'. Consensus clinical impression was used to determine the final diagnostic 
category for each site imaged; performance of algorithms based on features of digital 
optical image analysis are reported relative to this diagnostic category. Sites with an 
initial clinical impression of normal were categorized with a diagnosis of 'Normal'. In 
cases where the impression of one of the expert observers differed from the other two, the 
diagnostic category assigned by two of the three observers was used. Measurements in 
which all three observers disagreed on the diagnostic category were excluded from the 
analysis; a total of four sites were excluded for this reason. 
Histopathologic evaluation was available for 57 sites imaged. In these sites, the 
results of diagnosis based on consensus clinical impression were compared to 
hisopathology. 
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4.2.3 Image Analysis 
White light reflectance images of each site were first examined; if a clinically 
apparent lesion was present, a region of interest (ROI) corresponding to the lesion was 
defined. If the area was clinically normal, a representative ROI was selected from the 
white light reflectance image. The same ROI was identified in each color fluorescence 
image of that site, and quantitative image features were calculated for each ROI. 
Images were analyzed to yield possible features for use in classification 
algorithms. The following metrics were generated for ROIs corresponding to lesions and 
contralateral normal measurements: the average intensity in the red, green and blue (RGB) 
channels, average values of the ratios of the R/G, R/B and B/G intensities, the average intensity 
following grayscale conversion, and the standard deviation of the RGB and grayscale intensity 
values. In addition, for eaeh ROI corresponding to a clinical lesion, we calculated the ratio of the 
metric for the lesion relative to that measured from the contralateral normal ROI in the same 
patient. We refer to these metrics as 'normalized ratios'. For measurements from 
clinically normal sites, normalized ratios were obtained by dividing each ROI in two and 
calculating the ratio of the metrics from the two resulting regions. 
We explored which of these features provided the best separation between non-
neoplastic oral mucosa and neoplastic oral mucosa. For calculation of sensitivity and 
specificity, sites with a diagnosis of 'Cancer' or 'High Risk' were considered to be 
neoplastic, while sites with a clinical diagnosis of 'Normal' or 'Low Risk' were 
considered to be non-neoplastic. Prior to feature selection, sites with a clinical descriptor 
of melanosis were excluded from the data set. These sites were easily identifiable from 
the white light reflectance images. Binary classification algorithms were developed 
using linear discriminant analysis with a single image feature as input. The same clinical 
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dataset was used to both develop the algorithm and to assess classification accuracy. For 
each image feature, diagnostic performance was assessed as the threshold was varied 
from the minimum to the maximum of its value to generate a receiver operating 
characteristic (ROC) curve. Classification performance measures, such as the area under 
the receiver operating curve (AUC), sensitivity and specificity at the Q-point, were 
calculated for each of the input metrics. 
4.3 Results 
Images from a total of 351 different anatomic sites were included in the analysis. 
261 of these sites were imaged from 76 patients and 90 sites were imaged from 33 normal 
volunteers. Table 4.1 provides a summary of the number of sites imaged by clinical 
descriptor and diagnostic category. A total of 222 sites had an initial clinical impression 
of normal and 129 sites had an initial clinical impression of abnormal. Of the 129 
abnormal sites that were later reviewed by expert observers, 8 sites with a clinical 
description of melanosis and 2 sites with a clinical description of OSF were later assigned 
a diagnosis of 'Normal'. Pathologic diagnosis was available for a total of 57 sites 
imaged; Table 4.2 summarizes the pathologic diagnosis and diagnostic category for these 
sites. 
Figure 4.1 shows typical white light reflectance and fluorescence images of each 
of the four diagnostic categories. Fluorescence images of sites with a diagnostic category 
of 'Normal' showed homogenous green mucosal fluorescence. Sites with a diagnostic 
category of 'Low Risk' or 'High Risk' exhibited a progressive loss of green fluorescence, 
while sites with a diagnostic category of 'Cancer' typically showed both a loss of green 
fluorescence and an increase in orange-red fluorescence. 
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Table 4.1. Clinical Descriptors vs. Diagnosis of Measured Oral Sites 
Clinical Descriptors 
Normal 
Melanosis 
Lichen Planus 
Oral Submucous Fibrosis 
Leukoplakia 
Leukoplakia/Hyperkeratosis 
Leukoplakia/Ulcer 
Erythroplakia 
Ulcer 
Ulcer/Cancer 
Cancer 
Total 
Diagnostic Category 
Normal 
222 
8 
0 
2 
o 
0 
0 
0 
0 
0 
0 
232 
Low Risk 
0 
22 
0 
8 
28 
0 
1 
0 
1 
0 
0 
60 
High 
Risk 
0 
0 
1 
0 
12 
1 
0 
2 
2 
1 
3 
22 
Cancer 
0 
0 
0 
0 
1 
0 
1 
0 
2 
2 
31 
37 
Total 
222 
30 
1 
10 
41 
1 
2 
2 
5 
3 
34 
351 
(' 
Table 4.2. Pathology vs. Clinical Diagnosis for Measured Oral Sites 
Pathology Status 
None 
Non-neoplastic 
Dysplasia 
sec 
Total 
Diagnostic Category 
Normal 
232 
0 
0 
0 
232 
Low Risk 
53 
5 
0 
2 
60 
High Risk 
7 
5 
0 
10 
22 
Cancer 
2 
1 
2 
32 
37 
Total 
294 
11 
2 
44 
351 
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Normal 
Abnormal 
Low Risk 
Abnormal 
High Risk 
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Figure 4.1. Images of lesions typical of the four diagnostic categories. White light images are 
shown on the left and fluorescence images on the right. The top row illustrates 'Normal' buccal 
mucosa, illustrating homogenous green fluorescence. The second row shows a site with a 'Low 
Risk' lesion of the buccal mucosa, with loss of fluorescence. The third row shows a site with a 
'High Risk' lesion in the buccal mucosa with loss of fluorescence. Bottom row illustrates 'Cancer' 
of the tongue, illustrating loss of green fluorescence and presence of orange-red fluorescence. 
Lesions are outlined in the image. 
Figure 4.2. White light images (left column) and fluorescence images (right column) of typical 
lesions with OSF (top row) and melanosis (bottom row). Areas with OSF show slightly increased 
green fluorescence. Melanosis is easily recognizable from the dark pigmentation in the white light 
image, and is associated with loss of fluorescence. 
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Table 4.3. Area Under the ROC Curve (AUC) of Top Five 
Image Features for Binary Classification of Oral Sites 
Features 
Normalized MFI Green channel 
Normalized MFI Blue channel 
Normalized MFI Red / Green channel ratio 
Normalized MFI Grayscale 
Normalized MFI Red channel 
AUC 
0.91 
0.91 
0.90 
0.89 
0.85 
MFI: Mean Fluorescence Intensity 
Figure 4.2 shows white light reflectance and fluorescence images of two 
potentially confounding lesions found in the study population - oral submucous fibrosis 
(OSF) and melanosis. In white light reflectance images, OSF sites exhibited a pale-white 
patchy appearance similar to leukoplakia. However, unlike leukoplakia which is often 
associated with decreased green fluorescence, no loss of fluorescence was observed in 
sites with a clinical description of OSF sites. Melanosis sites were easily recognized 
from the white light images as areas of dark pigmentation and were consistently 
associated with decreased green fluorescence. 
Algorithms based on individual image features were ranked according to the area under 
the ROC curve (AUC); Table 4.3 lists the AUG for the five algorithms with the best 
performance relative to expert diagnosis; all were based on normalized features of 
fluorescence images. The top three performing algorithms were based on the normalized 
mean fluorescence intensity (MFI) of the blue channel, the normalized MFI of the green 
channel, and the normalized ratio of red to green MFI. Linear discriminant analysis 
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involving combinations of image features did not significantly improve classification 
performance* 
Figure 4.3 shows scatter plots of the image features and corresponding ROC 
curves for classification algorithms which resulted in the best sensitivity and specificity 
respectively. Figure 4.3a shows the normalized MFI from the blue channel by diagnostic 
category for all sites. Those sites with a diagnosis of Normal and a clinical descriptor of 
rnelanosis or OSF are shown separately. Sites with a diagnosis of 'Low Risk', 'High 
Risk' or 'Cancer' exhibit decreased normalized blue MFI compared to 'Normal' sites. 
Sites with melanosis show decreased normalized blue MFI, while those with OSF have 
similar normalized blue MFI to other 'Normal' sites. Figure 4.3b shows the ROC curve 
for the algorithm based on normalized blue MFI, excluding melanosis from the analysis. 
The operating point indicated on the ROC curve corresponds to a sensitivity of 92% and 
a specificity of 84%; the threshold values corresponding to this operating point is a 
normalized blue MFI of 0.86, which is indicated by the solid horizontal line in Fig. 3a. 
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Figure 4.3. (a) Scatter plot of the normalized blue MFI for all sites measured by diagnostic category, 
(b) ROC curve for diagnostic algorithm based on normalized blue MFI to differentiate between non-
neoplastic sites (Normal, LR and OSF) and neoplastic sites (HR and Cancer). Measurements with 
melanosis were excluded from algorithm development and testing. The open circle on the ROC 
curve indicates the Q-point. (c) Scatter plot of the normalized ratio of red to green MFI for all sites 
measured by diagnostic category, (d) ROC curve for diagnostic algorithm based on normalized ratio 
of red to green MFI to differentiate between non-neoplastic sites (Normal, LR and OSF) and 
neoplastic sites (HR and Cancer). Measurements with melanosis were excluded from algorithm 
development and testing. The open circle on the ROC curve indicates the Q-point. 
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Figure 4.3c shows a scatter plot of the normalized ratio of red to green MFI by 
diagnostic category for all sites. Sites with a diagnosis of 'Low Risk', 'High Risk' or 
'Cancer' exhibit an increased normalized red to green MFI ratio compared to 'Normal' 
sites; the normalized red to green MFI ratio increases on average as the severity of the 
diagnostic category increases from 'Low Risk' to 'Cancer'. Sites with melanosis show 
an increased normalized red to green MFI ratio, while those with OSF have a similar 
normalized red to green MFI ratio as other 'Normal' sites. Figure 4.3d shows the ROC 
curve for the classification algorithm based on the normalized red to green MFI ratio, 
excluding melanosis from the analysis. The operating point indicated on the ROC curve 
corresponds to a sensitivity of 90% and a specificity of 87% relative to the gold standard 
of consensus clinical impression. The threshold value corresponding to this operating 
point is a normalized red to green MFI ratio of 1.11, and is indicated by the solid 
horizontal line shown in Fig. 3c. 
4.4 Discussion 
This pilot study demonstrates that objective analysis of fluorescence images 
obtained with a low-cost imaging system can classify sites as neoplastic or non-neoplastic 
with high sensitivity and specificity relative to the gold standard of consensus clinical 
impression. The performance of this low-cost, objective system compares favorably to 
results reported for pilot studies of other optical imaging systems. A recent review by De 
Veld summarizes several clinical studies of optical imaging with qualitative image 
analysis for detection of oral neoplasia and reports sensitivity ranging from 63% to 100% 
and specificity from 79% to 96%.'' More recently, Lane et al. achieved a sensitivity of 
98% and specificity of 100% using qualitative assessment of fluorescence images 
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acquired with the VELScope to discriminate dysplasia and cancer from normal oral 
mucosa.9 Roblyer reported quantitative analysis of fluorescence and reflectance images 
obtained with a multi-spectral digital microscope to classify oral premalignant lesions 
and oral cancer with a sensitivity of 94% and specificity of 87%.94 Using the low-cost 
optical imaging system described here, we find similar sensitivity and specificity. 
The optical characteristics of oral lesions found in this high-risk population are 
similar to those in other studies. Our finding of decreased fluorescence associated with 
neoplastic lesions is consistent with reports in the literature. This loss of 
autofluorescence has been attributed to a decrease in collagen cross-links associated with 
neoplastic transformation.96 Our results also indicate a relative increase in red 
fluorescence for neoplastic sites. Other studies have made similar observations, 
attributing this increased red fluorescence to porphyrins. " ' " In addition, our 
threshold value for normalized red to green MFI ratio of 1.11 to differentiate neoplastic 
sites from non-neoplastic tissue is well in agreement with that of 1.09 found by Roblyer 
at 450-nm excitation. 
We characterized the optical properties of two types of potentially confounding 
lesions, melanosis and OSF, specific to the geographic region. Melanosis is usually 
benign and not considered to be precancerous.56 Our results indicate that sites with 
melanosis exhibit decreased fluorescence, but can easily be recognized by their 
characteristic appearance in white light reflectance images. The loss of autofluorescence 
in melanosis is likely due to strong absorption of light by black pigmentation in the 
superficial epithelium. In contrast to melanosis, the malignant transformation rate of OSF 
has been estimated to be between 3% and 19%.55 Most of the OSF sites measured in this 
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study were graded as 'Low Risk'. We found that the OSF sites imaged here did not 
exhibit loss of fluorescence. Histologically, OSF is characterized by juxtaepithelial 
fibrosis, along with atrophy or hyperplasia of the overlying epithelium, keratinizing 
metaplasia, and accumulation of hyalinized collagen beneath the basement membrane.97" 
99
 All of these constituents are strong sources of autofluorescence and may contribute to 
autofluorescence observed in our images of OSF sites. 
While the sensitivity and specificity reported here are encouraging, there are a 
number of limitations of this study. First, the same dataset was used both to develop 
classification algorithms and to assess their performance; in this situation, potential over-
training can inflate estimates of sensitivity and specificity. Results must be verified in an 
independent validation set. Second, the gold standard used to assess algorithm 
performance was consensus clinical impression; due to resource limitations, 
histopathologic diagnosis was not available from all sites. Table 2 provides a comparison 
of consensus clinical impression to histologic diagnosis of the 57 sites for which 
histology was available. Using histology as a gold standard to evaluate the ability of 
consensus clinical impression to discriminate neoplastic and non-neoplastic sites, results 
in a sensitivity of 96% (44/46); too few non-neoplastic sites were biopsied to estimate 
specificity of clinical impression in this study. Finally, a large number of 'Low Risk' 
sites were misclassified as neoplastic by the optical algorithms presented here. It is 
interesting to note that 'Low Risk' sites with consensus among all three expert observers 
were more likely to be classified by the optical algorithms as non-neoplastic (6/10 = 
60%) than were 'Low Risk' sites where only two of the expert observers agreed (13/30 = 
43%). Additional studies with histologic endpoints for all sites are required to assess the 
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ability of quantitative optical image analysis to aid in the evaluation of low risk oral 
lesions. 
4.5 Conclusion
 v .' 
The clinical study presented here demonstrates the ability to identify neoplastic 
and non-neoplastic oral tissue in vivo objectively using the portable, low-cost imaging 
system. Although further work is needed to address the limitations in this study, results 
from this pilot study suggest that this simple imaging device can potentially improve oral 
screening efforts in low-resource settings where clinical expertise and resources are often 
limited. 
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Chapter 5 
Optical Imaging of Pre-cancers with Structured Illumination: An Integrated 
Approach.1 
5.1 INTRODUCTION 
In the past decade, optical technologies have emerged as promising tools for the 
diagnosis of various epithelial cancers including esophagus, oral, and cervical pre-cancer. 
The need for noninvasively screening of large populations for these cancers has 
motivated the advancement of optical imaging technologies such as optical coherence 
tomography (OCT) and confocal microscopy.12 Due to their ability to provide diagnostic 
information at sub-cellular spatial resolution in real-time, optical imaging tools have the 
potential to better direct or replace routine biopsies in cancer screening and early 
detection.12"13 Moreover, the sensitivity and specificity of these optical methods has the 
potential to surpass that of conventional histopathology. However, more emphasis is 
needed to optimize these tools for use in vivo imaging as well as to examine other optical 
imaging alternatives which produce the same diagnostic ability but at a lower cost. This 
is crucial since large percentages of the population most at risk to develop oral, cervical 
and other cancers are found in developing countries where cost is a major deterrent to 
routine screening. Thus, alternative methods to high-cost screening, which can perform 
real-time diagnosis, can have a major impact on reducing mortality rates. 
!This chapter is modified from: T. Tkaczyk, M. Rahman, V. Mack, K. Sokolov, J. 
Rogers, R. Richards-Kortum, M. Descour, "High resolution, molecular-specific, 
reflectance imaging in optically dense tissue phantoms with structured-illumination," 
Opt. Express 12,3745-3758(2004). 
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Confocal scanning optical microscopy has emerged as a technique which exhibits 
several advantages over conventional optical microscopy. The important feature of 
confocal microscopy is the fact that out-of-focus blur is absent in confocal images, 
yielding the capability for non-invasive optical sectioning of both in vivo and in vitro 
specimens. This leads to the possibility of generating (3D) images of thick transparent 
objects such as biological cells and tissues. The simple and inexpensive alternative to 
confocal microscopy is the structured-illumination technique proposed by Neil, et al.77 
This method uses the principle that all but the zero (a.k.a. DC) spatial frequencies are 
attenuated with defocus. This observation provides the basis to obtain optically sectioned 
images from a conventional widefield microscope. A modified illumination system of the 
microscope projects a single spatial frequency grid pattern onto the object. The 
microscope then images faithfully only that portion of the object where the grid pattern is 
in focus. The structured-illumination technique requires acquisition of at least three 
images to remove illumination structure and reconstruct an image of the layer. The 
technique has been already applied to small pollen grains in reflectance77 mode and cell 
monolayers in fluorescence mode.78 Recently, the technique was implemented 
commercially by ZEISS100 in the ApoTome and Thales Optem in OptiGrid101 heads for 
inverted microscopes and fluorescent applications. Additionally the system was 
commercialized for industrial applications (MEMS testing) by Thales Optem.101 
Recently, confocal microscopy has shown promise to image the morphologic 
features of precancerous lesions in epithelial tissue.13'58 The simplicity of the structured 
illumination technique provides a convenient alternative to obtain this useful diagnostic 
information. There is however no example of successful reflectance and fluorescence 
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structured illumination imaging of dense tissue samples. The difficulty, especially in 
reflectance imaging, arises from the very strong out-of-focus contributions compared to 
the optical-section signal. The useful in-focus information is limited to even as low as 
two gray levels of the camera, and standard algorithms are not capable of effectively 
reconstructing images of the in-focus section under these conditions. Furthermore, 
reflectance imaging of tissue is generally sensitive only to non-specific differences in 
refractive index, and provides rather limited information about the range of molecular 
changes associated with patho-physiology. Therefore, to overcome these problems two 
actions were undertaken: (1) the sine approximation algorithm was applied for image 
reconstruction and (2) targeted contrast agents were used to provide a molecular specific 
source of increased signal from cells overexpressing cancer-related biomarkers. 
Sine approximation algorithm differs from conventional structured illumination 
reconstruction in that more images per sample layer are acquired to account for non-
optimized parameters in structured illumination imaging. These non-optimized 
parameters can include: (a) a systematic error in the stepping size of grid pattern, (b) 
random additive noise, (c) contribution of out-of-focus scattered light and (d) limited 
dynamic range of the detector. A detail discussion of this algorithm addressing each of 
these parameters can be found in Ref 102. To enhance the contrast for imaging of 
precancerous specimens, contrast agents that are molecular specific to cancer biomarkers 
were utilized. Antibodies against the epidermal growth factor receptor (EGFR), a 
receptor commonly overexpressed in cancerous and precancerous tissue, was used to 
target the contrast agents. After integrating these two approaches, high resolution images 
were obtained from biological specimens that were representative of normal and 
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precancerous tissue. For this, multi-layer epithelial cell phantoms were created with cells 
expressing levels of EGFR typical for normal and neoplastic tissue. These phantoms 
were used to demonstrate the optical sectioning ability of structured illumination in 
optically dense tissue samples and to image morphologic features of precancerous 
lesions. 
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Figure 5.1. Layout of the typical structured illumination microscope system. Adapted 
fromref. 102 
5.2 MATERIALS AND METHODS 
5.2.1 Structured Illumination Setup 
In order to implement structured illumination technique for imaging precancer, a 
Zeiss Axiovert 100M microscope was modified such that grid patterns can be projected 
on the focal plane of the microscope. A schematic of the modified microscope is shown 
in Fig. 5.1. The grid structure was placed at the conjugate focal plane in the back of the 
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microscope. The rectangular grid structure with 10 lines/mm or 100 urn period (Edmund 
Optics) was precisely driven by an actuator (SMAC-10) which had a stepping size of 
0.5um, The actuator could be programmed such that it would have all movement 
positions pre-recorded in its memory and would precisely move to those locations as 
commanded. An Olympus MD Plan 20x and a Zeiss 63x water immersion objective lens 
with a N.A. of 0.50 and 0.95 respectively were used for the experiments. A halogen lamp 
(100 watts) was used as an illumination source. Light from the lamp was collimated and 
redirected onto back of the objective lens to the sample with a 30/70 beam splitter 
(Chroma Tech. Corp.). The reflected light from sample passed through the beam splitter 
and was projected to the eye-piece and camera. All images were acquired using a 12-bit 
monochrome CCD camera (Hamamatsu Orca-1) mounted on top of the microscope. Both 
the camera and the actuator were controlled in AxioVision software provided by Carl 
Zeiss Inc. In order to automate the image acquisition procedure, a program was written in 
Visual Basic software that could move the actuator driven grid pattern and acquire image 
from the camera in a synchronizing fashion. 
In order to reconstruct optically sectioned image, the sinus approximation 
algorithm was used. The sine approximation algorithm applied here in the context of 
structured-illumination has been previously used to monitor vibrations103"105 and to 
measure shape100; however, in the context of image processing, this is a new approach. 
The algorithm is very robust and, most importantly, it works correctly for significantly 
smaller dynamic range than is required by conventional structured illumination imaging 
techniques. In order to evaluate the optical sectioning ability of the structured 
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illumination system, 15|j.m fluorescence beads were used as positive standards. Fig. 5.2 
shows fluorescence beads and the optical sectioned image. 
Figure 5.2. Fluorescence images of 15 urn bead: widefield image of beads with both in-
focus and out-of-focus beads (left), optically sectioned image of panel a with only the in-
focus bead obtained in structured illumination (right). 
5.2.2 Tissue Phantom Preparation 
To demonstrate the structured-illumination technique in dense biological tissue, 
tissue phantoms containing multiple layers of epithelial cells72 were prepared. These 
phantoms have optical, morphologic and molecular properties representative of normal 
and precancerous squamous epithelial tissue. The tissue phantoms were prepared using 
SiHa cervical epithelial cancer cells and MDAMB-435S breast epithelial cancer cells. 
The SiHa cells overexpress EGFR and provide a good model of neoplastic epithelium, 
while the MDA-MB-435S breast epithelial cells do not express EGFR, and in this regard, 
provide a good model of normal tissue. Phantoms of each epithelial cell line were 
prepared by resuspending cultured cells in a volume of buffered collagen type I to obtain 
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a cell density of 108 cells/ml. Collagen-cell suspensions were plated into 6.5 mm 
diameter transwells and allowed to gel at 37°C. The prepared tissue phantoms were 
allowed to grow in DMEM plus 5% FBS for 24 hours so that they formed a highly dense 
structure consisting of multiple layers of epithelial cells. The phantoms were determined 
to have a thickness between 400 and 600 um. 
In order to enhance the reflectance and fluorescence signal from cells, phantoms 
were labeled with molecular-specific contrast agents. For reflectance imaging with 
structured illumination, the contrast agent consisted of gold nanoparticles conjugated to 
anti-EGFR monoclonal antibodies to provide molecular-specificity. The gold 
nanoparticles were 20 nm in diameter with a peak scattering coefficient between 630 and 
680 nm. The monoclonal antibodies are molecular specific to EGFR, which is a 
transmembrane Mr 170,000 glycoprotein that is overexpressed in epithelial 
precancers.106"107 Both colloidal gold and EGFR antibodies have been used clinically 
previously. A solution of the anti-EGFR gold contrast agent was applied to the top 
surface of the prepared phantom for 10 minutes; phantoms were then rinsed with 
phosphate buffered saline (PBS) and imaged. Labeled MDA-MB-435S phantoms which 
do not express EGFR were expected to give very little reflective signal compared to that 
observed with labeled SiHa phantoms. Labeled SiHa phantoms which overexpress EGFR 
were expected to show clear labeling of cell membranes. As a control experiment to test 
for non-specific binding, a separate set of phantoms were also labeled with 20 nm 
diameter gold nanoparticles conjugated to non-specific IgG antibody and imaged; very 
little reflectance signal was expected under these conditions. 
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For fluorescence imaging, phantoms were first topically labeled with biotinylated 
anti-EGFR or non-specific IgG antibody followed by labeling of 655 nm streptavidin 
quantum dots (10-15 nm diameter) commercially available from QDot Corporation. The 
standard protocol provided by the manufacturer was followed in the quantum dot labeling 
procedure. A detail labeling step procedure for this can be found in Chapter 6. 
5.2.3 Image Acquisition 
Imaging experiments were carried out using a Zeiss 63x magnification water-
immersion objective lens with a NA of 0.95. The imaging configuration was diffraction 
limited and the transverse system resolution was approximately 0.4 urn. The maximum 
field of view of the imaging system depended on the magnification and parameters of 
CCD camera (Hamamatsu ORCA C4742-95) and was approximately 143 um x 108 urn 
However for the purpose of this study a region of 512 x 512 pixels was selected which 
corresponded to field of view of 54 um x 54 um. In order to reconstruct optical sectioned 
image with sinus approximation algorithm, a maximum of 64 images per layer were 
acquired. For one sample layer, a total acquisition time of 5 to 20 seconds was required. 
5.3 RESULTS 
Figure 5.3 presents imaging results for a phantom made of SiHa cervical cancer 
cells labeled with the anti-EGFR gold contrast agent. Figures 5.3(a), 5.3(b), and 5.3(c) 
show a conventional widefield reflectance microscope image, a structured-illumination 
raw image, and a reconstructed optical-section image, respectively. The reflectance from 
the colloidal gold particles can be appreciated at the cytoplasmic membrane of the SiHa 
cells which overexpress the EGF receptor. This characteristic "honeycomb" pattern is 
consistent with previous results reported in literature for this contrast agent using 
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conventional confocal microscopy. The result in Fig. 5.3(c) represents a layer 15-20 
um below the phantom surface. 
(a) (b) (c) 
Figure 5.3. Images of phantoms containing SiHa cervical cancer cells labeled with anti-
EGFR gold conjugates. The field of view is 54 x 54 um2. The approximate depth of the 
imaged optical section is 15-20 um below the phantom surface. Part (a) shows an 
inverted widefield reflectancemicroscope image. Part (b) shows a structured-illumination 
raw image. Part (c) shows a reconstructed optical-section image. 
Figure 5.4 shows imaging results for the MDA-MD-435S phantom labeled with 
the anti-EGFR gold contrast agent. Figure 5.4(a) and 5.4(b) show a structured-
illumination raw image and a reconstructed optical-section image, respectively. The 
image shown in Fig. 5.4(b) represents an optical section approximately 20 um below the 
surface of the phantom. The image in Fig. 5.4(b) is one of 25 optical sections scanned 
with 2 um axial increments through the tissue phantom. The resulting optically sectioned 
images of the 435 cells labeled with the anti-EGFR gold are very similar to the control 
images obtained with both the 435 cells and the SiHa cells labeled with the non-specific 
control antibody; the SiHa cells labeled with the specific antibody (Fig. 5.3) show much 
higher intensity as expected. The images in Fig. 5.4 (EGFR-negative cells labeled with 
the EGFR-specific contrast agent) provide an indication of the ability of structured 
illumination to image the native reflectance of tissue. In this case, we find that the image 
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detail present in both structured illumination and confocal images (data not shown) 
compares favorably, as does the penetration depth. 
(a) (b) 
Figure 5.4. Images of phantom containing MDA-MB-435S cells labeled with anti-EGFR 
gold conjugates. The field of view is 54 urn x 54 um. The approximate depth of the 
optical section is 20 um beneath the surface of the phantom. Part (a) shows a 
structuredillumination raw image. Part (b) shows a reconstructed optical-section image. 
In order to compare the structured-illumination results with a "gold standard" 
imaging system, confocal microscope images of the SiHa tissue phantom stained with the 
anti-EGFR gold colloid were collected. The confocal microscope (Leica TCS-4D) was 
used in reflectance mode at 647 nm illumination with a 63x, NA = 0.95 water immersion 
objective. Figure 5.5 presents a confocal-microscope image taken at approximately 15 
um below the surface of the phantom. There is a very good match in terms of contrast 
and detail between the images presented in Fig. 5.3(c) (structured illumination) and Fig. 
5.5 (confocal microscopy). It is worth noting that the structured-illumination microscope 
and the confocal microscope could image the same sample to a maximum depth of 50 
um. We found that this maximum depth was limited by the labeling technique rather than 
the performance of each instrument and its imaging modality. 
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Figure 5.5. Reflectance confocal-microscope image of the phantom containing SiHa cells 
labeled with anti-EGFR gold conjugates. The field of view measures approximately 60 
urn x 60 um. This field of view represents a segment of the full field of view of the 
confocal microscope chosen in size to match results obtained with structured 
illumination. 
(a) (b) 
Figure 5.6. Fluorescence image of SiHa cervical cancer cell phantoms optically 
sectioned with structured illumination, (a) Anti-EGFR targeted with quantum dot 
phantom representing cancerous tissue, (b) non-specific IgG targeted with quantum dot 
phantom. 
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Fig. 5.6 shows an optical sectioned image of quantum dot labeled SiHa cervical 
cell phantoms in fluorescence mode. As in Fig. 5.3 (c) (reflectance structured 
illumination) and Fig. 5.4 (reflectance confocal microscope), honeycomb pattern can also 
be seen with this quantum dot labeled phantom. 
5.4 QUANTITATIVE IMAGE ANALYSIS 
The reconstructed reflectance structured illumination images were analyzed 
quantitatively to determine whether image intensity parameters could be used to 
discriminate images of the phantoms representative of normal and neoplastic tissue. The 
mean signal intensity in the vicinity of the cell membrane were compared, since this is 
the area that is labeled with the anti-EGFR gold colloid. The mean reflectance intensity at 
the vicinity of the cell membrane was found for each of approximately five of the SiHa 
and 435S cell phantoms individually at a similar sample depth. Images from both 
phantoms were first multiplied by a single constant factor to enhance their brightness. 
The NIH freeware program ImageJ was then used to hand-segment the area of the cell 
membrane and calculate the mean reflectance value within the selected region. The 
average intensity of the cell reflectance signal was 62.5 gray-scale values for SiHa 
phantom Mneo = 62.5, substantially greater than the average 28.5 gray-scale reflectance 
signal for the MDA-MD-435S cell phantoms (M„orffI = 28.5). The corresponding standard 
deviations were pneo =. 4.9 and gn0nn = 3.5, respectively. The difference in the average 
membrane intensities is greater than the sum of the associated standard deviations, i.e. 
\(Mneo - {Mmrm)\ > (o-neo - onorm): |62.5 -28.5| = 34.0 > (4.9 + 3.5) = 8.4. 
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5.5 CONCLUSION 
In summary, the feasibility of the sine approximation algorithm applied to 
structured-illumination imaging was demonstrated. Additionally structured-illumination 
imaging in reflectance and fluorescence mode of optically dense tissue phantoms were 
successfully performed. The results compare very favorably with "gold standard" 
confocal microscope images of the same phantom. The phantoms representative of the 
optical and molecular properties of neoplastic and normal tissue labeled with a simple 
optically active, molecular-specific contrast agent can be distinguished quantitatively 
using optical-section image data that have been collected and an image-analysis metric 
that is sensitive to the difference in labeling based on molecular biomarkers of precancer 
and cancer. 
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Chapter 6 
Imaging performance of a miniature integrated microendoscope1 
6.1 OVERVIEW 
This chapter presents imaging performance of a miniature microdendoscope 
developed by Descour et al.108 for early detection of oral cancer. The instrument is 
designed to image in fluorescence or reflectance, in widefield, or with optical sectioning 
using structured illumination.77 The performance of the integrated miniature microscope 
was evaluated by imaging fixed biological samples acquired by the microendoscope to 
demonstrate its ability to image the cellular structure of tissue. This multi-modal 
miniature microscope is referred to as the 4M device. A rendering of the complete 4M 
device conceptual design is shown in Figure 6.1. 
Descour et al. presented the concept, design, and fabrication technology used in 
the 4M device, including descriptions of the mounting method and conceptual system 
design,108-111 printed lens fabrication,112 optical design for stray light reduction,113 
detector design,114 and a method of optical sectioning.102 The emphasis of this research 
work was the demonstration of imaging cultured cells and prepared tissue in vitro using 
the 4M system. 
'This chapter is modified from: Jeremy D. Rogers, Sara Landau, Tomasz S. Tkaczyk, 
Michael R. Descour, Mohammed S. Rahman, Rebecca Richards-Kortum, Ari H. O. 
Karkainen, and Todd Chiistenson, "Imaging performance of a miniature integrated 
microendoscope," J. Biomed. Opt. 13, 054020 (2008). 
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Figure 6.1. Rendered design of the 4M device that illustrates optical components 
mounted on the MOT substrate. In the future completed device (not shown), the image 
sensor is to be mounted on a PCB and attached to the 4M device walls. Adapted from ref 
116. ' 
The 4M device has a numerical aperture (NA) of 0.4 and a magnification of 4x 
with a 250 um-diameter field of view (FOV) and a working distance of 300 um. The 
device uses a 650-nm peak wavelength for reflectance imaging and 450-nm excitation 
with 655-nm emission for fluorescence imaging. The source used for each mode are high 
brightness LED of the appropriate peak wavelength, which is coupled to the system by a 
power delivery fiber. 
6.2 IMAGING OF BIOLOGICAL SPECIMENS 
The long-term goal of the research work is to utilize the 4M device to detect 
precancerous lesions in squamous epithelial tissues especially in the oral cavity and 
cervix. To image the morphological and biochemical changes associated with precancer 
in these sites, multiple imaging modalities may be required. Thus, two 4M devices with 
different modalities were considered for imaging relevant biological specimens: one 
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setup with a fluorescence imaging capability, and the other with a reflectance imaging 
capability. The differences between the two systems were the illumination sources and 
the beamsplitter coatings, as described earlier. To evaluate the performance of the 4M 
device in each of the modalities, exogenous contrast agents were used to label the 
biological specimens. The contrast agents provided two advantages: an increased SNR of 
the samples compared to their native contrast, and molecular imaging of specific 
biomarkers of interest, specifically the epidermal growth factor receptor (EGFR) in 
human oral precancerous cells. 
For fluorescence imaging with the 4M device, samples were labeled with 
quantum dots. Quantum dots are highly stable semiconductor nanocrystals with a high 
quantum yield, which results in a much higher signal and SNR than typical 
autofluorescence signals from tissue. Moreover, their emission wavelengths are tunable 
with their size, allowing one to image in the near-infraRed (NIR) region of the spectrum 
where the penetration depth of light in tissue is higher. For this study, CdSe quantum dots 
(QD655, Invitrogen) were chosen, which have a broad excitation range from 300 to 500 
nm and a narrow emission peak at 655 nm. For reflectance imaging with the 4M device, 
the specimens were labeled with 40 to 55-nm gold nanoparticles. Recently, gold 
nanoparticles were shown to be potential contrast agents for in vitro molecular imaging 
of precancerous cells by Sokolov et al.72 and El-Sayed et al.115 The particles have the 
ability to resonantly scatter light in the visible and NIR wavelengths depending on their 
size and shape. The protocol provided in Ref. 72 was followed to synthesize the 40 to 55-
nm gold particles, which had a peak scattering coefficient wavelength between 630 and 
680 nm. 
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Since the goal in this work was to demonstrate the high resolution imaging ability 
of the 4M device optical system in relevant biological samples, biological specimens that 
closely approximated those organ sites with a squamous epithelium where the 4M system 
is intended to be used were chosen—for example, the oral cavity and cervix. Due to the 
structural and biomolecular similarity between the oral cavity and cervix, only oral 
epithelial cells and tissue were chosen for the experiments. As mentioned earlier, contrast 
agents were used for molecular imaging of EGFR molecules, which are transmembrane 
glycoproteins that are over-expressed in both oral and cervical premalignant cells and 
tissue.106"107 Initial experiments were carried out on 3-D tissue phantoms made from 1483 
human oral carcinoma cells. Phantoms were prepared by re-suspending approximately 10 
million cells in a volume of buffered collagen type I according to a procedure developed 
by Sokolov et al.72'102 Collagen-cell suspensions were plated into 6.5-mm-diameter 
transwells and allowed to grow for 24 hours to allow the cells to develop a 3-D network 
within the collagen matrix. Prior to imaging, the phantoms were labeled with appropriate 
contrast agents. 
To label the phantoms with quantum dots, an indirect two step labeling procedure 
was followed. Prior to primary labeling, the phantoms were incubated in a 1% bovine 
serum albumin (BSA) solution for 15 minutes to block any nonspecific labeling. The 
phantoms were then incubated in a 500 \iL solution of biotinylated anti-EGFR (clone 
111.6, Lab Vision). After 1 hour of primary labeling at 24°C, excess antibodies were 
removed from the phantoms by washing them in phosphate buffered saline (PBS) two 
times. 
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A 500 nh solution of 10-nM streptavidin-coated quantum dots was prepared in a 
lxPBS for secondary labeling A 500 nL solution of 10-nM streptavidin-coated quantum 
dots was prepared in a lxPBS for secondary labeling. After 30 minutes of secondary 
incubation at 24°C, the phantoms were again washed in PBS to remove unbound 
quantum dots. Appropriate control samples, including nonspecific biotinylated anti-
human goat IgG (BA-3000, Vector) and secondary only labeling, were also prepared. To 
label phantoms with gold nanoparticles, antibody-gold conjugates were first prepared 
according to the protocol presented in Ref. 72. The procedure involved preparing a 
mixture of colloidal gold particles and anti-EGFR monoclonal antibodies at 0.10 mg/mL 
(clone 29.1, Sigma) in a 20-mM HEPES buffer with a subsequent addition of 
polyethylene glycol (PEG) and centrifuging the mixture at 5000 rpm for 2 hours to 
collect the bound conjugates. The phantoms were then incubated in a 500 ^L solution of 
the prepared conjugates for 1 hour at 24 °C in the presence of 10% dimethyl sulfoxide 
(DMSO) and washed twice in PBS to remove the unbound conjugates. DMSO was used 
as a permeation enhancer for the contrast agents. Control phantoms were similarly 
incubated with a nonspecific mouse IgG antibody-gold conjugated solution and washed 
in PBS. All phantoms were fixed in 10% formalin after labeling to preserve their natural 
structural integrity prior to imaging with the 4M devices. 
The imaging setup for both of the 4M devices were conducted on an optical relay 
system with a color CCD camera (ECO 13 80, Prosilica) as mentioned earlier. In 
fluorescence mode, the gain setting of the CCD was increased to optimize the signal-to-
background ratio. The CCD was color-balanced prior to the imaging experiment. All 
imaging experiments were carried out in a PBS immersion for index matching by 
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bringing the 4M device lens into contact with the wet sample and then focusing back to 
the tissue plane of interest. The surface tension maintained the immersion of the 4M 
device to distances well beyond the working distance of the 4M device. The specimens 
were transferred to microscope slides and mounted on a micrometer for precise focusing 
of the sample on the 4M device. To compare the performance of the 4M devices, all 
samples were subsequently imaged with a Zeiss Axiolmager Zl microscope. A 20x dry 
objective lens with a NA of 0.6 was used for imaging, and images were acquired with a 
color CCD camera (AxioCam Mrc5, Zeiss). A quantum dot 655-nm filter set (Chroma 
Technology, U.S.) was used to image the fluorescence samples. 
6.3 RESULTS 
Figure 6.2 shows widefield fluorescence images of 1483 oral carcinoma cells in 
phantom acquired with the Zeiss Axiolmager Zl microscope and with the 4M device. 
The last image in the row is the IgG control specimen. The results show clear labeling of 
the targeted biomarkers around the cell membrane in the EGFR-positive sample, but no 
labeling in the control sample. 
Figure 6.3 shows widefield reflectance images of the phantoms labeled with gold 
nanoparticles. The widefield images show the morphological pattern characteristic of 
single backscattering; however, the background associated with multiple light scattering 
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Figure 6.2. Widefield images of cells labeled with fluorescent quantum dots imaged with 
the 4M device (center) and with a Zeiss Axiovert 100M for comparison (left). Cell 
membranes are clearly visible in each image. A control sample with nonspecific IgG 
labeling is shown on the right. The scale bar is 25 um. 
Figure 6.3. Widefield image of cells imaged in reflectance labeled with gold 
nanoparticles. The image taken with the 4M device (right) shows the significance of the 
internal lens surface reflections. The bright region on the right of the image is due to a 
single surface reflection from an AR-coated lens. A similar image taken with a Zeiss 
Axiovert 100M is shown (left) for comparison. Black circular masks limit the FOV to 
250 um for each image. 
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from cell layers underneath reduces the image contrast. The 4M image is intermediate 
between the two—the single backscattering morphology is clearly visible in the center 
of the field, but the multiple scattering again reduces the image contrast somewhat. These 
results clearly demonstrate the ability to image backscattered light from cells in the 
current 4M device. 
To demonstrate the imaging feasibility of the 4M device with more complex biological 
specimens, porcine epithelial tissue were chosen because it is readily accessible and its 
morphological features are somewhat similar to those of human epithelial tissue. For 
sample preparation, fresh tissues were obtained from a local abattoir, and 6-mm punch 
biopsies were taken from the buccal mucosa of the porcine oral cavity. The tissues were 
then fixed in 10% buffered formaldehyde for 24 hours to preserve their structural 
integrity for a longer period. The tissues were sliced transversely in 200 to 300 \im 
thickness using a Krumdieck tissue sheer (Munford, Alabama). Tissue slices were 
subsequently labeled with contrast agents. For fluorescence imaging, the tissues were 
labeled with streptavidin-coated 655-nm quantum dots using the two steps indirect 
procedure described earlier. For positive labeling, biotinylated anti-swine IgG (BA-9020, 
Vector Lab) antibodies were used (0.15 mg/mL in lx PBS). Samples were also prepared 
that included primary labeling with anti-mouse IgG (Labvision) and secondary-only 
labeling for control. No attempt was made to label the porcine tissues with gold 
nanoparticles due to the 4M device's lack of contrast in reflectance mode as experienced 
with the phantoms. Figure 6.4 shows widefield images of the porcine epithelial tissue 
taken with the Zeiss Axiolmager Zl microscope and with the 4M device. Although the 
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signal was weak in the 4M image due to a limitation in the excitation power, squamous 
epithelium cells can still be appreciated from the image. 
Figure 6.4. Widefield fluorescent images of porcine epithelial tissue labeled with 
quantum dots taken with a Zeiss Axiolmager Zl (left) and with the 4M device (center). 
Squamous epithelial cells can be appreciated in both images. A control image is shown 
on the left. The scale bar is 25 um. 
6.4 CONCLUSIONS 
The results presented here demonstrate the ability to image fixed biological 
samples using the miniaturized microscope. Both reflectance and fluorescence imaging 
modalities can be used to acquire high-quality images of cells and epithelial tissues in 
vitro. Although further work is needed to use the device in vivo in a clinical environment, 
the results suggest that the 4M device can be used with targeted contrast agents to image 
the molecular features of cancer and its precursors. Furthermore, its application can 
potentially be extended to other areas of disease diagnosis where widefield microscopy is 
commonly used. 
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Chapter 7 
Conclusions 
7.1 Summary of Results 
The main objective of this research was to develop optical imaging systems that 
are low-cost, portable and can aid in screening and detection of oral cancer. Recent 
cancer facts and figures indicate that over two-thirds of oral cancer cases and three-
quarters of deaths due to the disease occur in developing countries where resources are 
often limited.2 No satisfactory mechanism exists currently to screen and detect early 
neoplastic changes of the oral cavity in the general population. Optical imaging 
technologies have the potential to aid in the identification of oral cancer and its 
precursors. Translating these technologies to developing countries and low-resource 
settings where the vast majority of oral cancers occur, thus, can be an important 
contribution to global efforts to reduce oral cancer mortality and morbidity. 
This dissertation presented two imaging systems that are low-cost, portable and 
can aid in screening and detection of oral cancer in resource limited settings. The first 
system is a low-resolution wide-field imaging system designed to screen surface area of 
oral tissue at risk to detect abnormal sites with high sensitivity. The second system is a 
high-resolution microscopic system designed to detect molecular changes in tissue to 
achieve high diagnostic specificity. In addition to developing the above two imaging 
platforms, the imaging performance of a miniature microscope developed by Descour et 
al. was evaluated as a part of this dissertation work. 
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The third chapter of this dissertation describes the design and construction of a 
low-resolution wide-field imaging system that is low-cost, portable and has multi-modal 
imaging capabilities in-vivo. Simple modifications to a surgical headlight system was 
made that enables direct visualization and digital image acquisition from oral tissue in 
multiple imaging modes including fluorescence, white-light reflectance, and orthogonal 
polarization reflectance. The multi-modal imaging system uses light emitting diodes 
(LEDs) to illuminate the oral mucosa. For fluorescence imaging, the system has a blue 
LED with an excitation peak at 455 nm wavelength; for white-light reflectance imaging, 
it has a white LED with an illumination range of 400 to 700 nm. Images can either be 
observed visually or captured digitally through a set of optical filters using an integrated, 
miniature charge coupled device (CGD) camera. The system is connected to a laptop via 
a firewire interface to record and store the images. The portable system weights only 3 
pounds and can be powered by a lithium-ion battery. Overall, the design of this system 
makes it low maintenance, affordable and adaptable to adverse conditions in developing 
countries and remote settings. The chapter ends with presentation of a brief set of clinical 
images obtained from patients in-vivo. The results demonstrate that it is an attractive 
technology to explore for oral cancer screening in low-resource environments where 
clinical expertise is often unavailable. 
The fourth chapter of this dissertation presents evaluation of the simple, low-cost 
wide-field imaging system described in Chapter 3 in a resource limited setting where oral 
cancer is prevalent. A clinical study was conducted at Tata Memorial Hospital (TMH) in 
Mumbai, India using this system. Reflectance images with white light illumination and 
fluorescence images were obtained from 261 sites in the oral cavity from 76 patients and 
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90 sites in the oral cavity from 33 normal volunteers. Quantitative image features were 
used to develop classification algorithms to identify neoplastic tissue, using clinical 
diagnosis of expert observers as the gold standard. Using the ratio of red to green 
autofluorescence, the algorithm identified tissues judged to be cancer or clinically 
suspicious for neoplasia with a sensitivity of 90% and a specificity of 87%. The study 
found optical characteristics of oral lesions in this high-risk population to be similar to 
those in other similar studies reported in the literature. The study also investigated the 
optical properties of two potentially confounding lesions that is population specific to 
south Asia. Although there were several limitations to this study, results from the pilot 
study suggest that the performance of the simple, objective low-cost system has potential 
to improve oral screening efforts, especially in low-resource settings. 
The fifth chapter describes modification of a conventional wide-field microscope 
to obtain high-resolution imaging as an alternative approach to complex and expensive 
confocal microscopy. Novel, optically active contrast agents (i.e. gold nanoparticles and 
quantum dots) were utilized to label disease-related biomarkers and increase the signal to 
signal-to-noise ratio (SNR) in structured illumination microscopy of biological tissue. 
Reflectance and fluorescence imaging results for multi-layer epithelial cell phantoms 
with optical properties characteristic of normal and cancerous tissue labeled with the 
contrast agents were presented. Structured illumination images reconstructed with the 
sine approximation algorithm94 compared favorably to those obtained with a standard 
confocal microscope. The results demonstrates that the concept of integrating structured 
illumination with optically active contrast agents can be a useful tool for simple and small 
imaging platforms for high-resolution molecular-specific imaging of precancer. 
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The sixth chapter describes imaging performance of a multi-modal miniature 
microscope (4M device) developed by Descour et al. Imaging performance was 
evaluated in fluorescence and reflectance mode using thin layers of fixed cells and 
excised porcine epithelial tissue from the oral cavity. Imaging results suggest that the 4M 
is capable of imaging biological specimens and has potential for in vivo applications. 
7.2 Future Directions 
The pilot study conducted for clinical evaluation of the PS2 system demonstrates 
that the system has the potential for screening and early detection of oral cancer with a 
high sensitivity. However, a large number of oral sites that were graded as 'Low Risk' 
by the expert observers in the study were misclassified as neoplastic tissue, resulting in 
poorer specificity than desired. This can lead to a large number of false positives in the 
general screening population. One approach to address this limitation would be to utilize 
high-resolution optical imaging system that has higher specificity to eliminate the false 
positives from the wide-field imaging system. Various high-resolution optical imaging 
methods including structured-illumination described in the second part of this dissertation 
has been proposed for early detection of precancer and cancer. Of particular interest is the 
low-cost fiber microendoscopy system developed by Muldoon.17 The author has 
demonstrated that the microendoscopy system could qualitatively and quantitatively 
differentiate between normal and cancerous tissue based on sub-cellular image features. 
Future studies that can combine the two imaging systems of wide-field imaging 
and high-resolution imaging to achieve high sensitivity and specificity would be an 
important contribution towards assessment of optical imaging as screening tool for oral 
cancer. Due to limited field-of-view in high-resolution imaging systems, the fiber 
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microendoscopy does not allow screening of surface area at risk. The wide-field imaging 
capability of the PS2 system can be used for identification of oral tissue that is at risk 
while the fiber endoscopy can be used for detailed assessment of the suspicious areas to 
detect a variety of morphologic, architectural, biochemical and molecular features of 
early neoplasia. Further, quantitative analysis of image features from the two systems 
can be combined to determine whether the two imaging systems together will yield 
classification schemes with higher sensitivity and specificity. Finally, because of the low 
cost and portability of these two optical systems, the study can be easily conducted in a 
resource-limited region with high-risk populations for oral cancer. 
7.3 Conclusions 
The two imaging systems described in this dissertation can potentially be useful 
tools for screening and early detection of oral cancer resource limited settings. In 
particular, the low-cost, portable imaging system can become a valuable aid for health 
care professionals in resource limited settings where clinical expertise is unavailable for 
identification of cancer and precancerous lesions. 
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